Skip to content
FIND A HEALTH VALLEY ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

On this page you will find all the latest news regarding BioAlps affiliated members and life sciences activities in western Switzerland.

All the latest press articles featuring BioAlps can be found in our Media Center on our About page.

ERC grants

Researchers based in Switzerland can once again apply for ERC grants

As negotiations between the EU and Switzerland have been officially launched today, researchers based in Switzerland can now once again…

Alithea-seed-extension

Alithea Genomics closes CHF 2.8 Million in seed financing extension

This milestone marks a significant step forward in the company’s journey to revolutionise large-scale RNA sequencing and transcriptomics.    …

Perivision-us fda

PeriVision announces FDA registration for its medical software VisionOne™

PeriVision, proudly announces its recent FDA registration for its first medical software product VisionOne.     This significant milestone marks…

Pristem-radiology-center

Pristem affordable radiology thrives in South Africa

A few months ago, Pristem’s South African subsidiary opened its first state-of-the-art, affordable radiology center in the township of Alexandra….

IOnctura-FDA

US FDA grants Orphan Drug Designation for iOnctura’s Autotaxin cancer therapy

iOnctura’s autotaxin inhibitor cambritaxestat for the treatment of pancreatic cancer gets Orphan Drug Designation (ODD) by the US FDA.  …

Debiopharm-wee1

Debiopharm launches expansion of WEE1 inhibitor

Debiopharm aims to further characterise the safety, tolerability, and preliminary anti-tumour activity of its potent WEE1 inhibitor Debio 0123 as…

abcd x-andalusian-hospital

Collaboration between ABCDx and Andalusian Hospitals

ABCDx is collaborating with Andalusian hospitals to improve stroke triage inside ambulances.     Thanks to a public-private grant from…

International women days

Six women-centred initiatives you should know about

From successful entrepreneurs to academics and industry leaders, the Swiss Health Valley is full of inspirational women working in life…

HUG-RLT

A multidisciplinary HUG team launches a new study of innovative radioligand therapy (RLT)

A new radioligand to treat glioblastoma and digestive tumors evaluated as a world first at the Geneva University Hospitals (HUG)….

Terapet receives EUR 1.68 Million Eurostars grant

Terapet announced the receipt of a non-dilutive grant totalling approximately EUR 1.68 Million from the European Commission through the Eurostars…

FIT-artiria-planny-algorized

Artiria Medical, Planny and Algorized receive support from FIT

The three startups have received financial support from the Foundation for technological innovation (FIT). Artiria Medical gets a Tech Growth…

Dopamine

Dopamine production is not behind vulnerability to cocaine abuse

A UNIGE team shows that our ability to produce dopamine – the «happiness hormone» – is not correlated with increased…

Agora Care celebrates 10’000 patients and a new collaboration with Caduceo

The Campus biotech startup, recruited over 10’000 patients on its Agora Care platform.     This marks an inflection point…

FONGIT FIF

FONGIT Innovation Fund (FIF) awards funding to Geneva-based tech projects

A seed loan of CHF 100,000 has been granted to previous FIF Grant laureate and HUG spinoff HeroSupport. One grant…

Artiria Medical

Artiria Medical successfully secures USD 6 Million

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first…

Leenaards prize

Leenaards Prize awarded to two CHUV research groups

The two Leenards scientific prizes were awarded to research groups led by CHUV researchers.     Each year, the Leenards…

New Biologix - licensing

NewBiologix announced a licensing agreement with Florabio AS

NewBiologix SA announced a licensing agreement with Florabio AS to genetically engineer their proprietary HEK293 cell line.     NewBiologix’s…

Aktiaa secures 27M

Aktiia secures CHF 27 Million

The Neuchâtel-based startup secures CHF 27 Million (USD 30M) in funding from Khosla Ventures and Others.     Aktiia mission…

Future of health march 204

Future of Health Grant unveils its March 2024 cohort

Startups Resilient SA and Maven Health are among the eight new startups selected by the Future of Health Grant (FoHG)…

ArgaMedtech-series b

Argá Medtech SA closes oversubscribed Series B

Argá Medtech announces €54 Million oversubscribed series B capital raise.     The round was led by the existing investors,…

Prix strategis

Two life sciences startups shortlisted for the 31st Prix Strategis

Testmate Health and Seprify are among the eight semi-finalists of this year’s Prix Strategis.     Every year for almost…

Albionic-Patrick pestalozzi

Abionic appoints Patrick Pestalozzi as new CEO to propel company into next growth phase

Abionic SA, a Swiss leader in nanofluidic point-of-care diagnostic solutions, announced the appointment of Patrick Pestalozzi as its new CEO,…

CSEM bioreactor

CSEM and ClexBio create a bioreactor to manufacture tissue-engineered cardiovascular implants

A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio,…

Biopole review 2023

The Biopôle Review – 2023 edition

Check out all the key figures from Biopôle’s community, inspiring interviews and more in their latest review.     Biopôle,…

Atinary-takeda-partnership

Atinary and Takeda collaborate to drive innovation in healthcare

Atinary Technologies, a Vaud based startup, announced a strategic collaboration with Takeda, Japanese largest pharmaceutical company.     This partnership…

UNIGE-innovative materials-bacteria

Innovative materials to combat bacteria

A UNIGE team is developing new alloys with bactericidal properties to combat antibiotic-resistant germs.     While crucial to biotechnology,…

Alys Pharmaceuticals

Alys Pharmaceuticals launches with $100 Million financing from Medicxi

Formed through the aggregation of six-asset centric Medicxi companies, including Aldena Therapeutics, Alys boasts a robust R&D pipeline of cutting-edge…

Prof. Antoine Geissbuhler BioAlps President

“Bringing meaning back to the healthcare professionals”

Appointed Dean of the Faculty of Medicine at the University of Geneva, Professor Antoine Geissbuhler, is also Director of Teaching…

Multiwave technologies

Multiwave Technologies partners with Aix Marseille University

Multiwave Technologies brings to market a portable MRI device powered by metamaterial technologies and AI software. ​ The partnership includes joint research…

BioSpectal

Monitor your blood pressure with OptiBP, a Biospectal application

Patients can measure their blood pressure in 30 seconds by placing their fingertip on the camera lens of a smartphone….

BioLizard

BioLizard chooses Biopôle for its Swiss subsidiary

BioLizard is a Belgian bioinformatics, data analytics and data management service and consulting company heading digital transformation in the life…

Oryl Photonics

Oryl Photonics raises CHF 830,000 in seed funding

The Vaud-based startup announces the successful conclusion of a CHF 830,000 seed fundraising. The round is backed by Swiss investors,…

CSEM Inventor Award

CSEM Inventor Award granted to spaceCoder

Shedding Light on Precision: CSEM spaceCoder technology is a game changer in the field of precision measurement     In…

GeNeuro

Successful € 5 Million Capital Increase for GeNeuro

GeNeuro, a Geneva-based biopharmaceutical company focusing on treatments for neurodegenerative and autoimmune diseases, including multiple sclerosis (MS), amyotrophic lateral sclerosis…

Nicolas Durand 2

Nicolas Durand appointed Director of the Campus Biotech Foundation in Geneva

Dr Nicolas Durand will step down from his CEO role at Abionic on 29 February to be at the steering…

Swiss Venture Capital Report

CHF 870 Million invested in Swiss medtech and biotech companies

In the midst of an unfavourable environment, the life sciences’ sector continues to attract investors in Switzerland according to the…

Debiopharm

Debiopharm and TransCode Therapeutics Collaborate to Develop Targeted Nucleic Acid Therapeutics for Cancer

TransCode Therapeutics is a RNA oncology company based in the United States committed to more effectively treating cancer using RNA…

InvestPro Programme Vaud

Vaud: a CHF 90 Million plan to tackle the shortage of healthcare staff

The Vaud State Council has drawn up a CHF 90 Million “far-reaching plan” to meet the challenges presented by the…

Transmutex

Transmutex raises CHF 20 Million

The Geneva-based company, founded in 2019, has secured new funding to further develop its research into safer, cleaner and cheaper…

Pfizer Foundation Prize

Pfizer Research Prize: 3 Researchers From The Swiss Health Valley Awarded

13 young researchers from Fribourg, Geneva, Basel, Bern, and Zurich have won a 2024 Pfizer Research Award.   Since 1992,…

Prof. Jabaudon

The Roger de Spoelberch Prize Awarded to a UNIGE Researcher

Professor Denis Jabaudon, Director of the Department of Basic Neuroscience and member of the Synapsy Center for Neuroscience Research in…

Lonza Visp

Lonza Achieves Strong Financial Results in 2023 Amid Leadership Transition

The Swiss CDMO announces robust sales of CHF 6.7 billion, delivering 10.9%1 CER sales growth, and the nomination of Jean-Marc…

Stämm

Stämm chooses Valais to set up its European team

The Argentinian biomanufacturing innovator is launching its R&D facility at the BioArk in Monthey     Founded in 2016 in…

PhenomX Health

PhenomX Health and Issviva launch a programme to help women manage Stress and Sleep during Menopause

In a pioneering partnership, Issviva Menopause and the Swiss startup PhenomX Health have united their expertise to empower women navigating…

LightHouse

The Lighthouse Partnership: a Swiss cooperation to propel AI-Guided Neuromodulation

This 4 years partnership is funded with CHF 18 Million from the Wyss Center, and involves EPFL Neuro X Institute,…

Fluosphera

FluoSphera is awarded a CHF 1.1 million grant from Innosuisse

FluoSphera S.A., a biotechnology company developing versatile and disruptive in-vitro solutions for drug discovery to predict drug efficacy and safety…

FIT - Jan 2024

Maven Health, NeoSens and NADUP supported by the FIT

Three life science projects have received support from the Foundation for Technological Innovation (FIT) in the form of Tech Grants:…

Novostia_implantation

First-in-Human implantation for Novostia’s heart valve

The Vaud-based startup, located at the Biopôle, successfully implanted its TRIFLO valve in a human.     Novostia, a pioneering…

Debiopharm-innovation-fund

Debiopharm Innovation Fund invests in MedaSystems

MedaSystems secures additional funding from Debiopharm Innovation Fund to accelerate global access to pre-approval treatment.     Medasystems, a pioneer…

FIT - Doopl and Rea

FIT loans CHF 500,000 to Doppl and CHF 100,000 to Rea Diagnostics

DOPPL, a leader in organoid engineering for disease modelling and personalised medicine, has received a Tech Growth loan of CHF…

Cellestia-innosuisse-grant-2

Cellestia secures a CHF 2 Million grant from Innosuisse

The Biopôle based startup was awarded an Innosuisse Grant to advance a groundbreaking Graft versus Host Disease prevention therapy.  …

Novartis - Calypso

Calypso enters into agreement to be acquired by Novartis

Calypso’s shareholders will receive an upfront payment of $250 Million upon closing and are eligible to receive up to $175…

Timeline

Timeline raises CHF56 Million and partners with L’Oréal

Already backed by Nestlé, the Swiss Health Valley startup co-founded by former EPFL President Patrick Aebischer, now counts a second…

Debiotech

Debiotech launches its engineering house

New year, new challenges! Debiotech, a leader in medical technologies based in Lausanne – Switzerland, announces the launch of its…

Tune Insight Team

Tune Insight leads a €1.8 Million project for data collaboration in paediatric emergency units

The EPFL spin-off has created a technology able to move past privacy and security issues for data sharing. The project,…

Stalicla SA

Stalicla Secures $17.4 Million in Series B Financing

The Geneva-based clinical-stage biopharmaceutical company is advancing precision medicine pipelines for neuropsychiatric and neurological disorders     STALICLA announces the…

The Sense Baby Study

Babies prefer human voices

The brains of 4-month-old babies respond preferentially to the human voice over sounds from their environment. This is confirmed by…

Kickfund Venture

Kickfund Ventures: CHF 70 Million for Swiss deeptech startups

The fund, backed by a diverse group of investors, including anchor investors Ernst Göhner Stiftung and Gebert Rüf Stiftung, will…

Socorex and CSEM

Socorex wins the CSEM Digital Health Journey Award

This SME based in Ecublens (VD), is a world leader in development and manufacture of high-end precision dosing instruments for…

Ferring

Ferring and PharmaBiome enter into a new microbiome R&D collaboration and exclusive licensing agreement

Collaboration leverages the proven development and commercial capability of Ferring with PharmaBiome’s compelling technology to research, develop and manufacture novel…

The Swiss HealthTech Center in Biel

Thanks to its location, diverse culture, extensive experience and infrastructure, Switzerland Innovation Park Biel/Bienne (SIPBB) is the perfect platform to…

Fongit Innovation Fund

4 life sciences projects supported by the FIF

Four Geneva-based technology projects have won funding from the Fongit Innovation Fund (FIF) for their innovations. A seed loan of…

ASPIVIX

ASPIVIX receives CE Mark approval for Carevix™

ASPIVIX, announced that carevix™, its novel Cervical Stabilizer, has attained CE marking. This next generation medtech device for routine procedures…

Gliapharm

Alzheimer Research: Gliapharm raises CHF 3.65 Million

The Alzheimer’s Drug Discovery Foundation (ADDF) invests CHF 3.64 Million in GliaPharm to advance its lead programme to accelerate the…

Aesyra

Aesyra raises CHF 2.6 Million

The Vaud-based and EPFL spin-off develops oral appliances preventing sleep bruxism and sleep apnea. The seed financing round was led…

Vandria

Vandria Announces a CHF 18 Million Fundraising

The $20.6M (CHF 18M) round was led by ND Capital together with a small syndicate of HNW private investors. The…

NEWS BIOPOLE

What all life sciences start-ups should know about fundraising

The Biopôle campus in Lausanne brings together some of the world’s most innovative life sciences companies. But how does an…

Haleon PVEI

Haleon awarded by the Prix Vaudois des Entreprises Internationales (PVEI)

Haleon, a former division of GSK that became independent in 2022, won the jury’s award in the “Foreign company” category….

Orio Therapeuthics

A CHF 40,000 Grant from Venture Kick to Orio Therapeuthics

Orio Therapeutics has won a CHF 40,000 Venture Kick prize, alongside KIDEMIS and Rheo, with a project designed to reduce…

AC Immune

Dr. Madiha Derouazi becomes AC Immune’s CSO

Dr. Madiha Derouazi is the founder of the Swiss biotech AMAL Therapeutics and the former CEO of German-based company Speransa…

Diatheris 1

A CHF 2.5 Million Grant for Diatheris

The Leona M. and Harry B. Helmsley Charitable Trust in the United States supports the Diatheris project, a UNIGE spin-off…

LLM EPFL

EPFL publishes a Large Language Model for medical knowledge

Researchers at EPFL’s Faculty of Computer Science and Communications have developed two large language models (LLMs) specialising in the healthcare…

Siegfried - Marcel Signer

Siegfried in Evionnaz: 150 years of pharmaceutical innovation

About fifty people from the Swiss Health Valley had the chance to visit the Siegfried production site in Evionnaz, during…

B Levrat HUG

Bertrand Levrat leaves the HUG

Bertrand Levrat, CEO of the University Hospitals of Geneva, joins Mediclinic, a private group   Bertrand Levrat, Chief Executive Officer…

Senbiosys Velia Smart Ring

Velia Smart Ring raises already CHF 1.5 Million

After raising CHF 622,672 on Kickstarter, Senbiosys launched another campaign on Indiegogo and already raised about CHF 1.5 Million for…

Digisanté

CHF 400 Million for Digisanté, a programme to transform the Swiss Healthcare system

The Swiss Federal Council wants to start Digisanté, a programme for the digital transformation of the healthcare system. The aim…

Biped.ai

Biped.ai raises CHF 1,2 Million

The EPFL spin-off created a harness acting as a copilot for visually-impaired people     “This funding round will help…

ProSeed

ProSeed wins a CHF 100,000 loan from FIT

Giving a second life to brewing by-products     ProSeed’s mission is to transform the Swiss food industry by upcycling…

Sitem Insel - DIC

A moving X-Ray Machine for research on joints and bones

Sitem-insel has inaugurated Europe’s inaugural Dynamic Imaging Center (DIC). This cutting-edge laboratory captures X-ray images of individuals in motion, presenting a…

Mara Graziani

Mara Graziani receives the prestigious Latsis Prize

Mara Graziani, research assistant at the HES-SO Valais-Wallis, has been awarded the prestigious Latsis prize worth CHF 25,000, which rewards…

FIF Nov 2023

TheraPPi Bioscience, MPC Therapeutics SA and dEEgtal awarded by the FIF

The Fongit Innovation Fund (FIF) has awarded three Geneva-based life sciences projects for their groundbreaking innovations.     A seed…

CSEM Insel Partnership

A new medtech hub in Bern

The Canton of Bern wants to establish itself as a leading international medical location by 2030. To achieve this, the…

Comphya

Comphya SA announce successful inaugural surgery for erectile dysfunction in Spinal Cord Injury Patients

The first implantation of CaverSTIM, the medical devices invented by Swiss company Comphya, in spinal cord injury individuals has been…

BioAlps Awards 2023

BioAlps Awards 2023

Dr. Hervé Bourlard receive the BioAlps Academia Award, and Dr. Igor Fish and Dr Nicolas Mermod receive the BioAlps Industry Award.

.Neurorestore

An implant to restore walking in Parkinson’s patients

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL, Inserm and the University of Bordeaux have designed a neuroprosthesis to correct the gait disorders…

Novochizol SA

Cancer Research: CHF 1.1 Million for Novochizol SA

Cancer: EPFL and Novochizol SA to collaborate on designing more efficient immunotherapies, with the support of Innosuisse, the Swiss Innovation Agency.

Debiotech

DEBIOTECH, your local expert and partner for the development of medical devices

Debiotech is delighted to support catalysing innovation and advancing healthcare. The Swiss medtech company is proud to be part & contribute to BioAlps Networking Day 2023 on 9 November 2023 at Campus Biotech.

Mass Challenge Award 2023

Impossible Materials wins the Mass Challenge Diamond Prize

The University of Fribourg chemtech spin-off has been granted CHF 120,000 in cash. The start-up provides cellulose white pigment solutions…

HUG Award

HUG wins award for smarter medicine in intensive care

At the 46th World Hospital Congress organised by the International Hospital Federation (IHF), the University Hospitals of Geneva (HUG) received…

FIT Impact: 3 life sciences projects awarded

The first cohort to benefit from FIT Impact is now known. This programme run by the Foundation for Technological Innovation…

Abionic

LASCCO SA and Abionic SA announce a partnership to commercialize a sepsis diagnostic solution in China

LASCCO SA and Abionic SA, both based in Biopôle in Epalinges, announced that they have signed a licensing agreement with…

FONGIT - FIF Oct 2023

EarlySight SA and ArtemiX Biotech SA supported by the FIF

Two Geneva-based life sciences startups have been awarded the Fongit Innovation Fund (FIF) for their innovative projects. A seed loan has…

Debiopharm Valais

Debiopharm invests CHF 30 million in a life sciences building in Valais

This new facility will host some 2400 m2 of research laboratories, in Martigny where Debiopharm’s workforce jumped from 150 to…

HUG Innovation DAY 2023

HUG Innovation Day: A Pioneer Of New Therapies For Deafness Awarded

On the occasion of their 17th Innovation Day, held on 19 October, the Geneva University Hospitals (HUG), in partnership with…

Lagosta

Lagosta partners with Merck for the distribution of Chitosan

LAGOSTA S.A. announces that it has entered into a collaboration with the global science and technology company Merck for the…

Ibex™ Lonza facilit in Visp Switzerland

Lonza: 300 jobs in Visp for a new vaccine

Lonza’s Visp site is preparing to manufacture components of a vaccine to protect against pneumococcus. Hundreds of jobs are at…

Hedera Dx

Hedera Dx Launches Blood Based Cancer Testing

Hedera Dx, a Vaud-based oncology company specializing in liquid biopsy testing, has unveiled a fully streamlined solution that allows hospitals…

SOPHiA GENETICS

SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca

The three companies will collaborate to address global inequalities in comprehensive cancer care, and to improve global access to advanced…

Emovo Care

Emovo Care receives a CHF 100’000 FIT loan

The FIT (Fondation pour l’Innovation Technologique) in Canton of Vaud supports Emovo Care with a FIT Tech Seed loans of…

Limula BioTools Innovators

Limula wins the $250,000 BioTools Innovator Grand Prize

BioTools Innovator, a Los Angeles-based accelerator focused on life science tools companies, awarded Limula the grand prize of the BioTools…

CNS Therapy

CNS Therapy secures a CHF 1.1 Million investment

The Jura-based start-up, CNS Therapy, has raised a seed round funding totalling CHF 1 Million from private investors and CHF…

Smartcardia

SmartCardia received FDA clearance for its ECG monitoring patch and cloud platform

The EPFL-spin-off created the SmartCardia’s 7L patch, an easy-to-wear, cable-free, waterproof device that can be used for continuous monitoring for…

DayOne Tech

4 new Medtech Start-Ups join the DayOne Tech Accelerator in Canton of Jura

The DayOne Tech accelerator for medtech project is a pillar of the Jura’s medical technology economy. Four new start-ups joined…

Chuv Lymphoedema

Innovations at the CHUV in the treatment of lymphoedema

Swelling of one or more limbs as a result of lymphoedema – a common but little-understood condition – affects one…

Terapet + Korean

CHF 3 Million for Terapet and two South Korea partners

Terapet SA together with their South Korean partners Yonsei Cancer Center (Heavy Ion Therapy Center) and Oncosoft Inc. are awarded…

Mimix Biotherapeutics

A CHF multimillion investment for Mimix Biotherapeutics

Mimix Biotherapeutics in Biel (Bern) secures significant investment to translate and commercialize a new treatment technique for human tissue regeneration….

BioArk 3rd Building

BioArk Monthey: a 3rd building dedicated to life sciences and biotechnologies

BioArk is on a roll! The Monthey-based technology site, which is celebrating its 20th anniversary this year, inaugurated its third…

Lonza Visp

Lonza further expands in Visps thanks to a new partnership

A new agreement with an undisclosed global biopharmaceutical partner will quadruple current dedicated bioconjugation capacity by adding two new production…

Novostia

Novostia starts clinical trials of its new heart valve in Lituania

Novostia has received the green light from the Lithuanian State Health Care Accreditation Agency under the Ministry of Health to…

Medicrops

Medicrops acquires Swiss Alpinopharma

A strategic move to enhance digital patient care in the booming European cannabis market.     MediCrops Holding AG (‘MediCrops’),…

Aerium Therapeutics

Covid-19 Research: Aerium Therapeutics begins development of three in-licensed antibodies

Aerium Therapeutics, a company based in Lausanne and Boston, focuses on the development of antiviral therapeutics for COVID-19 and emerging…

Cancer Research: HES-SO Valais-Wallis and Debiopharm sign a partnership

The Life Technologies Institute of the Haute École d’Ingénierie has signed a new five-year collaboration agreement with Debiopharm Research &…

Professeur Nicolas Thomä

Cancer Research: ISREC Foundation and EPFL announce the creation of the Paternot Chair

The chair will be held by Professor Nicolas Thomä. The ISREC Foundation is contributing to the funding of the Chair…

HeroSupport

HeroSupport wins a CHF 150,000 Venture Kick Grant

The HUG and UNIGE spin-off wants to improve cancer treatment universal access with tailored patient-positioning medical devices and standardized workflows….

Tune Insight

Tune Insight raises CHF 3,1 Million

The round is led by 14Peaks Capital, with participation from investors including Inflection.xyz, Debiopharm Innovation Fund and Zurich Cantonal Bank….

Nagi Biocience

Nagi Bioscience secures CHF 12.4 Million Investment

Nagi Bioscience, a Swiss life sciences company developing next-generation laboratory equipment to unlock the full potential of alternatives to animal…

Debiopharm Innovation Fund

Debiopharm Innovation Fund: a new seed fund dedicated to Digital Health

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announces the launch…

Atinary

Atinary Technologies raises CHF 4.6 Million

The Biopôle-based start-up has developed a machine learning platform dedicated to materials discovery. The seed-round was round led by AgFunder…

Future of Health Grant

Future Health Grant – 9 new projects selected

This great Swiss Health Valley🇨🇭 initiative was started by CSS and EPFL Innovation Park to promote Medicine 3.0. The 9…

Future Health Lausanne

Future Health Lausanne, an opportunity for the Swiss Health Valley

Future Health Lausanne is taking place on 3 October 2023 at the Swisstech Convention Center in Lausanne. The event is…

Adiposs

Adiposs SA announced the completion of the phase I clinical trial of its ImageBAT™

Adiposs SA, a Swiss biotech company developing medical imaging products and technologies, announced the completion of the phase I clinical…

ADDEX Therapeutics

A consortium led by Addex Therapeutics secures a €4 million Eurostars grant

The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD).     The…

Multiwave technologies

Multiwave raises CHF 3.8 Million

Geneva-based deeptech startup Multiwave Technologies SA, led by Tryfon and Panos Antonakakis, is attracting new capital that will be dedicated…

Unige Cancer cells

Swiss Cancer Center Léman found a way to boost artificial immune cells to fight cancer

A team of Swiss researchers has discovered a way of prolonging the efficacy of CAR-T cells in immunotherapy for the…

Mecaplast Swiss - 4à6

A visit at Mecaplast Swiss

Over the decades, Mecaplast Swiss has extended its offering beyond plastic injection per-say. The company may collaborate as early as the design phase, up to shipping fully finished products to its clients across the globe. The new ISO 7 clean room strengthens the offer as it is mainly be dedicated to the post-injection operations, assembly, finishing and packaging to meet the fast-growing demand of the MedTech industry.

Ibex™ Lonza facilit in Visp Switzerland

Lonza to stop producing Moderna vaccine in Visp

Production of the Moderna serum will cease at Visp in the canton of Valais. In addition, Lonza’s Managing Director, Pierre-Alain…

Socorex - 60 years

Socorex, 60 years of success in precision volumetry

The story begins in 1963, in Canton of Vaud (Switzerland) with the know-how gathering of small companies active in manufacturing…

CUTISS AG

CUTISS AG launches its Series C funding round

CUTISS AG, a Swiss company specialising in regenerative skin medicine and tissue engineering, has announced the launch of its Series…

Grand Prix Economie Genevoise

Amal Therapeutics wins Geneva Innovation Prize

Les Grands Prix de l’économie 2023 are organised by the CCIG, with the support of the State of Geneva and…

Hybrid Brain Cell Unil and Wyss Center

A new brain cell discovered by Swiss researchers

The two major families of cells that make up the brain, neurons and glial cells, secretly hid a hybrid cell,…

100 startups

HAYA Therapeutics is Switzerland’s most promising startup

The 13th edition of the TOP 100 Swiss Startup Award celebrated Switzerland’s best startups according to a 100-person strong jury:…

Antion Biosciences

A breakthrough in the US for Antion Biosciences SA

Antion Biosciences SA (Antion), an innovative developer of cell and gene therapy technologies, announces the granting of a significant patent…

HCK Coreline

Healthcare Konnect (HCK) and Coreline Europe GmbH start a partnership

Healthcare Konnect (HCK) and Coreline Europe GmbH start a new partnership to amplify the inherent value of diagnostic accuracy.  …

Agora Care Pristem SA

Agora Care partners with PRISTEM SA

Two Western Switzerland startups join forces to revolutionize medical imaging   Agora Care is a Geneva-based company developing a patient-centered…

UNIGE Highway Code Cell

Deciphering the “highway code” of our cells

A team from UNIGE has identified a new process governing the growth of the ‘roads’ that enable cells to thrive….

ten23health

ten23 health expands sterile manufacturing capacity at its VIVA 1® facility in Visp

ten23 health®, a global contract development and manufacturing organization, announced a capacity expansion for the manufacture of sterile drug product…

Diatheris

CHF 40,000 For Diatheris

The Geneva-based biotech startup won Venture Kick’s second stage of financial and entrepreneurial support. The project aims to achieve optimal…

Neurosoft Bioelectronics 1

First in Human Recording of Brain Activities Achieved by Neurosoft Bioelectronics

The Swiss start-up created a stretchable high-channel electrode grid that was successfully used in a first-in-human clinical study in a…

CHUV@home

CHUV@home: an application to monitor patients after surgery

Nearly 1,800 people have already used the CHUV@home application since it was launched in 2021. Patients who have undergone surgery…

Campus Santé Sion

Pôle Santé Campus in Sion – Foundation stone laid

The Pôle Santé Campus in Valais will bring together on the same site training activities in health and social work,…

Genolier Innovation Hub

Genolier Innovation Hub: an ambitious medical center

In the heart of the Swiss Health Valley, the holding company AEVIS VICTORIA SA is investing more than CHF 100…

Alzheimer UNIGE HUG

A tool for predicting the future of Alzheimer’s patients

A team from the University and the HUG has determined which imaging technique is best for early detection of the…

Venture Leaders Medtech 2023

10 medtech projects were selected to join the Swiss National Startup team that will travel to Boston and Cambridge next…

Bearmind FIT

Bearmind reaches CHF 2 million funding

The start-up develops sensors and algorithms to provide a real-time assessment of the risk of concussion for professional athletes.  …

PhenomX Health SA

An app to empower women during their menopause

PhenomX Health SA, a femtech start–up based in Biopôle, launches a wellness and precision nutrition app for menopause care in Switzerland,…

UNIGE - oncology

UNIGE scientists identified genes involved in the progression of cancer

Tissues, blood vessels, cells: tumours develop in a complex ecosystem known as the tumour microenvironment.  A team from the University…

Gaia Tech AG

Gaia Tech AG raises CHF 480,000

The Bern-based start-up extracts natural antioxidants from agricultural waste and has successfully closed its pre-seed funding round with SICTIC business angels, Venture…

Epiterna

Epiterna raised €10 Million

The longetivity start-up, based at Biopôle, is funded by Prima Materia, the investment firm founded by Spotify founder Daniel Ek and…

Swissmedic

MRA between Switzerland and the USA in the area of Good Manufacturing Practice for medicinal products takes effect

The Mutual Recognition Agreement (MRA) between Switzerland and the United States in the area of Good Manufacturing Practice for medicinal…

Medicxi

Medicxi announces a $400m fund for life sciences projects

Medicxi, a leading European life sciences investment firm, announces its $400 million Medicxi IV fund. The new fund will continue…

CHUV - heart transplant

CHUV: a child on bi-ventricular cardiac assistance could be weaned off the machine and avoid a heart transplant

After spending a year in the Pediatric Intensive Care Unit at CHUV, a 4-year-old boy did not need a heart…

Givaudan Dairy Alternatives

Givaudan expands its Protein Hub in Zurich to create dairy alternatives

Geneva-based Givaudan has expanded the Protein Hub at its flagship Zurich Innovation Centre in Kemptthal, to support the growth of dairy…

Biopôle start-up fund

Sulfiscon and biped.ai recipients of the Biopôle Start-up Fund

The fund offers up to CHF 90,000 a year, over three consecutive years, to promising life sciences ventures.    …

Perivision

PeriVision raises between CHF 0.5 and 1 Million in a Seed Round

PeriVision is utilizing the power of artificial intelligence (AI), virtual reality (VR), and cloud computing to redefine eye testing and…

HUG HIV

A patient in remission from HIV after a bone marrow transplant

The HUG and the Institut Pasteur have announced an exceptional case of HIV remission. A promising discovery.   The patient…

biped.ai

Biped wins the Prix de la canne blanche

The Swiss Central Union for the Blind (UCBA) awards projects for blind, partially sighted and deaf-blind people. Twenty-one projects were…

Magali Bischof, BioAlps' Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch the video from 18'00. 

The Swiss Health Valley Region on One TV

Magali Bischof, BioAlps’ Secretary General is interviewed by Benjamin Smadja during the 13 World Chambers congress organised by CCIG Geneva. Watch…

ten23health

ten23 health announces expansion with the launch of quality control services

ten23 health® announces the launch of “quality control” service offerings in Switzerland for release and stability testing of clinical and…

Comphya

Comphya SA launches clinical study for erectile dysfunction in Brazil

After raising CHF 850 000 in January, and starting a clinical trial in Australia, the Swiss Medtech startup launches a…

4à6 La Tour

Innovation at Hôpital de la Tour

On Thursday 1 June, the Swiss Health Valley Community was received by Hôpital de la Tour in Meyrin during a…

Le Temps - Medtech

Le Temps – Medtechs still trapped in European reform on medical devices

Medical technology companies are still grappling with the new rules on healthcare devices and diagnostics, two years after they came…

Oncolifestyle - Debiopharm

Oncolifestyle, Debiopharm’s website to empower people living with cancer

The Swiss-based biopharmaceutical company launches a new online portal to support people with cancer, with an initial focus on prostate…

Prof. Antoine Geissbuhler BioAlps President

Prof. Antoine Geissbuhler appointed Dean of UNIGE Faculty of Medicine

BioAlps President, Prof. Antoine Geissbuhler, takes a new position. He is now at the helm of UNIGE Faculty of Medicine….

CHUV Immunotherapy

CHUV launches a new cellular immunotherapy to treat acute myeloid leukemia

This subtype of cancer, which is particularly aggressive in children and frequent in adults, responds poorly to current standard treatments….

Gender Medicine

Gender medicine: Switzerland invests CHF11 million

The Swiss government is investing CHF47 million in four national research programmes: gender medicine, biodiversity, new construction techniques and crop…

Dsm-Firmenich Adare Biome

dsm-firmenich invests € 275 Million into Adare Biome

Adare Biome, a unit of Adare Pharma Solutions (CDMO), is a historic player in the development and manufacturing of postbiotic…

Fongit Coaches

FONGIT Innovation Initiation Program for Life Sciences – and Deep Tech Projects

In 2016 FONGIT, in Geneva, and EPFL Innovation Park launched the Geneus program – the first innovation initiation program –…

AC Immune

AC Immune Receives FDA Fast Track Designation for its Alzheimer’s Vaccine candidate

Lausanne-based biopharmaceutical company AC Immune SA, announced that it has received Fast Track designation from the U.S. Food and Drug…

Défi Source 2023

Défi Source 2023 rewards 6 innovative projects focusing on people and society

Over 150 innovation and healthcare players attended the presentations of the 12 finalist projects during the finale of the second…

FIT

Dewi, DNAQuraCy, naialabs and MagFlow awarded grants from FIT

The FIT, (Fondation pour l’Innovation Technologique) in canton of Vaud awarded 4 promising Swiss Health Valley projects. DNAQuraCy spun out…

Isospec Analytics

Isospec Analytics wins CHF 150’000 and Venture Kick’s 3rd round

The startup uses molecular signatures that can be used like bar codes to identify molecules, and developed a technology to…

HUG Phage

A HUG patient saved by natural viruses called bacteriophages

For the first time, a multidisciplinary team from the University Hospitals of Geneva (HUG) and the University of Geneva (UNIGE)…

EBAmed

EBAMed raises EUR 14.35 Million in Series A Funding

The Swiss Health Valley start-up develops a novel image guidance system for the non-invasive treatment of Ventricular Tachycardia through Proton…

Venture Startup Competition

>>venture>> Startup Competition: Diatheris and ZiZAN!A Biobotanica awarded

Several Swiss Health Valley projects were rewarded during the finale of the >>venture>> Startup Competition on 26 June 2023, at…

Debiopharm

Debiopharm invests $6 Million with Benchstrength in Altis Labs

Altis Labs is a Canadian computational imaging company accelerating clinical trials with artificial intelligence.   “We are thrilled to partner…

Bloom Renewables

Bloom Renewables won the Prix Sud

Le Temps, and its main partner Romande Energie, announced the Sustainable Start-Up 2023 Prize   Bloom Biorenewables, a Fribourg based…

Lunaphore

Lunaphore Technologies to get acquired by Bio-Techne

Lunaphore Technologies SA, a Vaud-based (Switzerland) life sciences company developing technology to enable spatial biology in every laboratory, announced it…

CHUV

The ERAS protocol, developed at the CHUV, receives the “Nobel Prize for Surgery”

Under the guidance of its Director General Nicolas Demartines, the CHUV was the first hospital in Switzerland to adopt the…

W. A. de Vigier Award 2023

Three Health Valley projects received a W. A. de Vigier Award

biped.ai, Gaia Technologies and Limula received a W. A. de Vigier Award, each endowed with CHF 100,000. Over 300 submitted…

University of Bern

University of Bern strengthens research cooperation around healthcare in Africa

Together with African and European partner universities, the University of Bern is developing is establishing two long-term research collaborations. These…

bNovate

bNovate Technologies raises CHF 12 Million

bNovate Technologies, a leader in rapid bacterial detection systems for water, has announced a CHF 12 million Series C funding…

Lymphatica

CHF 400’000 for Lymphatica

The FIT (Fondation pour l’Innovation Technologique) gives a Tech Growth loans of CHF 400’000 to the EPFL spin-off, allowing her…

Swiss Medtech Award

Abionic wins the Swiss Medtech Award 2023

The EPFL spin-off, founded in 2010, wins the Swiss Medtech Award 2023 valued at CHF 75,000. Abionic specialises in providing…

Regen Lab

Regen Lab partners with Dassault Systèmes Group

Regen Lab, a Swiss commercial-stage medical technology company specializing in the research, development, registration, manufacturing and commercialization of proprietary tissue…

HUG RNA Vaccine

HUG to test a promising messenger RNA vaccine against melanoma

A messenger RNA vaccine developed by Moderna, which has recently been shown to be effective against certain cases of melanoma,…

Inselspital

Swiss and American researchers reached a potential milestone in cancer therapy

Researchers from the University of Bern, Inselspital, University Hospital Bern, and the University of Connecticut have made a significant breakthrough…

Merck Biotech Development Center

Merck inaugurates its Biotech Development Centre in Corsier-sur-Vevey

German laboratory Merck invested CHF 250 million in Corsier-sur-Vevey (VD). The 15,700 m2 building will combine research and production of…

Selexis - KBI

Selexis SA and KBI Biopharma now operate as one organisation

Selexis, an EFPL startup, was founded in 2001 before being acquired by the Japanese group JSR Life Sciences. KBI Biopharma,…

Ibex™ Lonza facilit in Visp Switzerland

Lonza acquires Dutch biotech company Synaffix

The Valais-based pharmaceutical subcontractor will pay an initial €100 million, with subsequent milestone payments of up to a further €60…

Yassin Nahi GGBa

Driving Growth and Innovation: Yassin Nahi’s Insights on the Biotech Cluster in Western Switzerland

The Swiss Biotech Report 2023 recently unveiled an impressive portrait of Switzerland’s thriving biotech sector. With record revenues of CHF…

CSEM and MOMM Diagnostics

CSEM and MOMM Diagnostics partner to develop a rapid test for preeclampsia

Among the various pregnancy complications, one of the most serious and potentially life-threatening conditions is preeclampsia affecting 3 to 8%…

Virus Grippe

How the flu virus hacks our cells

A UNIGE team has discovered how the influenza A virus hijacks the mechanism for importing iron into cells to invade…

Impossible Materials

Impossible Materials wins CHF 150,000

After raising CHF 3.8 Million last month, the Fribourg-based startup won the third and final stage of the Venture Kick…

Artiria Medical

Artiria receives FDA 510(k) Clearance for its deflectable guidewire for surgery

Artiria Medical, a Vaud-based neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by…

Onward

A paraplegic controls his movements with his mind

Neuroscientists and neurosurgeons from EPFL/CHUV/UNIL and CEA/CHUGA/UGA report in the journal Nature that they have re-established communication between the brain…

De Vigier Award

6 life sciences startups in the Top 10 of the W. A. de Vigier Award

From a record number of over 300 submitted projects, the jury picked their Top 10. On 20 June 2023, up…

FIF May 2023

Fluosphera SA, Kylys Aesthetics SA and Consulto supported by FONGIT

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has awarded two Seed loans of 100,000 CHF to Fluosphera SA and Kylys…

WS Digital Health

Western Switzerland cantons sign an agreement on digital health

Fribourg, Geneva, Jura, Valais and Vaud are aiming to establish a legal basis for the provision and operation of other…

Onward

Onward Announces First-in-Human Use of ARC-IM™ Lead to Restore Movement and Function after Spinal Cord Injury

New lead is purpose-designed to optimize the delivery of ONWARD ARC Therapy™   ONWARD Medical, a medical technology company working…

Innovators and Investors Connect

Investors et Innovators Connect

On 2 May 2023, BioAlps and Intuitive Surgical co-organised an  Investors et Innovators Connect event. Our association scouted projects in…

SAKK HUG

CHF 1 Million for a clinical study on Lymphoma

Dr Noémie Lang, oncologist at Geneva University Hospital (HUG), wins the prestigious Swiss Group for Clinical Cancer Research (SAKK) Trial…

BIND

BIND: Bioinnovation Day Awards

On 11 May 2023, 31 early stage life sciences projects were presented to the public at the AGORA (Fondation ISREC)…

New Biologix

NewBiologix is betting on the industrialization of gene therapy

With CHF 45 million raised, the start-up NewBiologix, officially launched on 11 May 2023 at the Biopôle in Epalinges, has…

Novostia

Novostia raises € 2.5 Million

Novostia SA is a clinical stage company developing a breakthrough artificial heart valve.   Founded in April 2017, in Neuchâtel,…

Swiss Health Valley Photo

BioAlps 20th General Assembly

Collaboration is key to foster innovation in the Swiss Health Valley   Founded in 2003, BioAlps empowers the Swiss Health…

Gnubiotics

Nobel Laureate Prof. James Rothman and Drug Discovery Expert Dr. John Baldoni join Gnubiotics as Senior Advisors

The Swiss company has been able to recreate the unique diversity of glycan structures found in breast milk, nature’s perfect…

HCK

HealthCare Konnect and Ligence Partners to Expand Access to AI-based Echocardiography Solution

The two companies join forces to bring AI-based echocardiography solution, Ligence Heart, in Switzerland and North Africa (Morocco, Algeria, Tunisia…

Domo Health + SAK

Domo Health partners with SAK to bring advanced digital health solutions at home

SAK (St. Gallisch-Appenzellische Kraftwerke AG) has acquired a participation in Domo Health as part of a round of capital raising….

Innosuisse Swiss Accelerator

Innosuisse grants CHF 2.5 M to 7 Swiss Health Valley Life Sciences Startups

Within the framework of the Swiss Accelerator, Innosuisse supports 53 innovation projects by SMEs and startups and grants each of…

Limula

Limula SA receives CHF 2.5 million from Innosuisse Swiss Accelerator

Limula SA receives CHF 2.5 million in non-dilutive funding to accelerate the industrialisation of a closed, automated, and modular solution…

machineMD

machineMD wins Innovation World Cup 2023

machineMD, a Bern-based medtech company, was awarded the top prize at the prestigious Innovation World Cup® 2023, hosted during the…

Siegfried

Siegfried expands and invests CHF 25 million in Evionnaz (VS)

The biomanufacturing company invests of up to CHF 25 million in Valais (Switzerland) for a new global R&D Center for…

SBA report

Biotech companies thrive in Switzerland

Swiss Biotech Report 2023 shows sector weathers global disruption well and continues to play a leading role driving global healthcare…

Impossible Materials

Impossible Materials raises CHF 3,4 Million

Suspected of causing cancer, titanium dioxide, a white colouring agent, has been banned from food in Switzerland and Europe since…

Prof. George Coukos

George Coukos honored by the American Association for Cancer (AACR)

George Coukos, full professor at the Faculty of Biology and Medicine of UNIL, director of the Department of Oncology UNIL-CHUV…

Distalmotion

Distalmotion raises $ 150M

The fundraise, led by Revival Healthcare Capital, will be used to get a Food and Drug Administration (FDA) approval for…

Senior Man and Music

Music practice keeps the brain from ageing

A study led by the UNIGE, HES-SO Geneva, and EPFL revealed that music practice and active listening could prevent working…

Nagi Bioscience's team

SydLab One by Nagi Bioscience hits the market

Nagi Bioscience releases an end-to-end automated device to screen drugs, chemicals and others substances on micro-organisms.   Swiss EPFL spin-off…

Euresearch

Horizon Europe for Swiss Researchers

Swiss entities can participate in most Horizon Europe calls. Funding is provided by the Swiss government as long as Switzerland…

Biopôle - LICR

Ludwig Cancer Research and Canton of Vaud Partner to Build a Research Centre

The new centre will be dedicated to synthetic immunotherapy and immune engineering on the Biopôle site in Epalinges.   The…

Wyss Center CEO

Erwin Böttinger is the new Wyss Center Geneva CEO

The Executive Board of the Wyss Center for Bio and Neuroengineering, a non-profit research center, is pleased to announce the…

Ibex™ Lonza facilit in Visp Switzerland

Lonza completed its latest drug manufacturing line in Visp

The new line will support customers with a range of drug product manufacturing needs for both clinical and commercial supply….

De Vigier Awards

W.A. de Vigier Awards 2023: 7 Western Switzerland Life Sciences Startups Selected

15 startups were selected among 300 projects. 5 of them are set to win CHF 100,000. The Award Ceremony is…

Obesity Center CHUV

An Obesity Center opens at the CHUV

The creation of an Obesity Center at the CHUV enables the teams of Dr. Lucie Favre, head of the Obesity…

Alithea Genomics

Alithea Genomics receives CHF 500,000 from FIT

The EPFL spin-off is active in high-throughput RNA sequencing, used to examine gene expression and discover new biomarkers and drugs….

Lunaphore

Lunaphore raises CHF 40 million in Series D1 funding

The Swiss startup plans to use the funding to strengthen its growing portfolio offering in spatial biology.     Lunaphore…

OramaVR

A VR training programme for medical students supported by Innosuisse

Viva VOsCE is a revolutionary project aiming at transforming medical education through harnessing the power of Virtual Reality (VR) technology….

FIF 2023

Three new projects financed in Geneva by the FIF

Plair, Endotelix and Dr Beat Walpoth received funding from the Fongit Innovation Fund (FIF).   Plair SA: Growth loan of…

Senbiosys

Senbiosys raises more than CHF 600,000 on kickstarter

Senbiosys developed a smart ring and an application to give users inputs about their health and wellness. The EPFL spin-off…

Tech4Eva 2023

Tech4Eva selected 16 projects for its 2023 programme

16 projects have been selected for the 2023 programme   Tech4Eva is an EPFL Innovation Park and Groupe Mutuel initiative…

Debiopharm Innovation Fund

Debiopharm and Merck invest in artificial intelligence

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital…

Medyria

EFI-Lake Geneva Ventures and Yellowstone Holding AG invest CHF 3,5 million in Medyria

Medyria’s PyCath aims to be the only device on the market with pressure and blood flow velocity sensing for the…

Sophia Genetics / Agilent

SOPHiA GENETICS and Agilent Partner

SOPHiA GENETICS, a Lausanne-based cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with…

GeNeuro

GeNeuro raises €25 million for its treatment against long COVID

GeNeuro develops timelimab, an antibody that showed promising results in treating inflammatory symptoms for long COVID patients   GeNeuro, a…

DayOne Tech Jura

Three Jura start-ups awarded with the DayOne Tech accelerator prize 

The Jura branch of the Swiss Innovation Park Basel Area is home to 28 companies and institutions, including ten in…

Debiopharm

Debiopharm expands its oncology pipeline

The Lausanne-based biotech company has obtained global rights from a Novo Nordisk molecule and plans to take the compound forward…

Raphaël Conz

Raphaël Conz is the New Head of Department for Economic Promotion and Innovation in the canton of Vaud

Raphaël Conz is also BioAlps’ vice-president. For many years, he has worked to promote the attractiveness and the reputation of…

Medistri

Medistri invests CHF 8 million in Domdidier

The largest independent sterilisation company in Europe invests to expand its plant in Domdidier, in the canton of Fribourg.  …

Oculis

Oculis Announces US public listing on Nasdaq

A Swiss Health Valley success story! Oculis goes public.   Oculis Holding AG (“Oculis”), based at EPFL Innovation Park in…

Comphya

Comphya receives approval for first pilot clinical trial in Australia

A swissmade neuromodulator to treat erectile dysfunction starts clinical trials in Australia   Comphya SA, developer of the first neuromodulator…

Fluosphera

FluoSphera Secures a Pre-Seed Investment of $ 1M 

The US accelerator IndieBio New York which is part of SOSV, Swiss-based Mountain Labs, and EFI Lake Geneva Ventures participated…

Lunaphore

Lunaphore and CRO Sirona Dx collaborate to expand COMET™ offerings to US-based biotech and biopharma customers

Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore’s flagship COMET™ spatial biology platform as a service….

Fondation Leenaards

Leenaards Foundation 2023 Science Prizes

Leenaards Foundation announces three winners of the 2023 Science Prizes. CHF 1.5 million are awarded to support biomedical research in…

Obseva

ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland

In financial trouble, the Geneva-based femtech company had to lay off its employees and reorganize its management   Obseva, in…

Terapet

Terapet raises CHF 2,3 million

The Swiss MedTech company is developing next generation imaging technology, and closed a Pre-Series A investment round. This funding supports…

MimiX - Precomb

mimiX Biotherapeutics and PreComb join forces to fight cancer

 The two companies are partnering to accelerate the process of personalized cancer drug profiling leveraging the potential of both company’s…

Mindmaze

Izar by Mindmaze, a new smart device to improve hand rehabilitation

MindMaze, a global pioneer in the development of AI-driven digital neurotherapeutics, is proud to announce the US and EU launch…

Future of Health

7 digital health start-ups selected by the Future of Health Grant

CSS and EPFL announce the 2nd cohort of the Future of Health Program   The Future of Health Grant (FoHG)…

SEED BIOSCIENCE

SEED Biosciences teams up with Molecular Device to market its DispenCell

Biopôle-based SEED Biosciences teams up with Molecular Devices, LLC. The American leading provider of high-performance life science solutions is now…

MintWorld

Lonza wants to encourage careers In Life Sciences and opens MINTWorld

Faced with a shortage of qualified personnel in the field of mathematics, computer science, natural sciences and technology (MINT) in…

Gene Predictis

Gene Predictis is bought by NIMGenetics

The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed.  …

Sofia Genetics

SOPHiA GENETICS Expands Partnership with AstraZeneca

The Swiss start-up, specialised in AI assisted medicine, and the Swedish-British pharmaceutical company want to create multimodal approaches for cancer drug…

13 Biotech to watch

13 biotech companies to watch according to BioAlps and Labiotech.eu

BioAlps recently collaborated with Labiotech.eu to detect the 13 biotech and healthtech companies in the Swiss Health Valley to watch…

Hopital La Tour

La Tour invests CHF 750 million in a health campus in Meyrin

Hôpital de La Tour in Geneva sells its premises to finance an ambitious innovation-oriented health campus   The owners of…

AC Immune MJFOX

CHF 500 000 for AC Immune

Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) provide more than USD 500,000 in…

Aspivix

Aspivix receives U.S. FDA Clearance for Carevix™, Their Novel Cervical Stabilizer

Carevix™, a novel atraumatic cervical stabilizer created by the Swiss startup ASPIVIX SA, received 510(k) clearance from the U.S. Food…

Biopôle Startup Fund winners 2022

Volumina Medical, Parithera and PeriVision win the Biopôle Startup Fund 2022

The initiative, which includes up to CHF 90,000 of support per year for up to three consecutive years, is designed…

CSEM + LIMULA

Limula and CSEM partner to automate the production of CAR T cells

A Health Valley partnership to revolutionize cancer therapies and to bring a personalised treatment for cancer patients   CSEM supports…

Calciscon

€2M Eurostars funding for a project led by Calciscon

CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer…

Xsensio

Xsensio announces an agreement with Mayo Clinic

Xsensio Announces Know-How and Stock Purchase Agreement with Mayo Clinic   Xsensio, a Vaud-Based company that is developing the Lab-on-Skin©…

CaverSTIM

Comphya raises CHF 850 000 in a convertible loan

Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced the fundraising of CHF 850k in a…

Pills ©maksim goncharenok

Research is less profitable for the pharmaceutical industry

According to a Deloitte study, investing in research is less and less interesting. The audit and consulting firm used figures…

Ibex™ Lonza facilit in Visp Switzerland

Lonza invested CHF 1 billion in Visp in 2022

The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total…

Alithea Chuv Pamgene

CHUV, Alithea Genomics and PanGene partner to develop a pan-cancer blood test

The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king…

Magali Bischof Labiotech

BioAlps and the Swiss Health Valley

Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role…

Chuv, Ludwig Institute, EPFL

CHUV, EPFL, SIB and Roche found molecules able to suppress resistance to immunotherapy

A breakthrough in the fight against cancer: researchers from EPFL, the Ludwig Institute of the CHUV, the SIB, and Roche…

HUG Center Virtual Medicine

The HUG open a Centre for Virtual Medicine

The new Centre for Virtual Medicine at the HUG is a pioneer in the use of virtual reality for clinical…

Bionomous

BIONOMOUS closes a USD 2.7 million Series A

The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion.  …

machineMD

Virtual reality glasses used as a diagnostic tool for brain disorders

MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a…

Neurosoft Bioelectronics

Neurosoft Bioelectronics receives ISO Certification for its Quality Management System

Neurosoft Bioelectronics SA, a startup developing implantable brain-computer interfaces, announces that it has received ISO 13485:2016 Certification by TÜV SÜD…

Bachem

A CHF 1 billion contract for Bachem Group

The contract covers the delivery of a large volume of peptides over a five-year period from 2025-2029, and follows the…

Ypsomed Innovation Award 2022 – The Winners

machineMD (1st place), Pace Locator (2nd place) and Compact Motion (3rd place). The Innovation Award, worth a total of CHF…

MPC Therapeutics

A CHF 1.5M seed-funding round for MPC Therapeutics to improve CAR-T cancer therapies

MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation.   The…

ten23 health

Swissfillon becomes ten23 health

ten23 health®, a global contract development and manufacturing organization (CDMO) announces the change in branding of its in Visp, Switzerland…

Stalicla

STALICLA signs exclusive in-licensing agreement with Novartis for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment

The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines for neurodevelopmental disorders and heralds the…

mimiX biotherapeutics Ltd

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin®

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin® MIMIX BIOTHERAPEUTICS LTD, a Swiss medical technology company…

Resistell

Resistell AG closes its series B first tranche of CHF 8.5 Million

Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should…

iOnctura

iOnctura awarded EUR 17.5 million funding from the EIC Accelerator

Funding will support iOnctura’s clinical program for IOA-289, a first-in-class autotaxin inhibitor for the treatment of pancreatic cancer   iOnctura…

Biped

An intelligent harness to facilitate the mobility of blind people

The startup Biped created a harness equipped with 3D cameras that beeps when there is a risk of hitting an…

AMF Medical SA

AMF Medical SA bought for CHF 200 million by Tandem Diabetes Care

Tandem Diabetes Care, a global US-Based insulin delivery and diabetes technology company, announced an agreement to acquire AMF Medical SA,…

Pharma Suisse

Swiss research: the pharmaceutical industry is the leading investor in 2021

In 2021, private companies spent CHF 16.8 billion in Switzerland on in-house research and development (R&D) activities. This represents an…

The Scientist

Nanolive selected in the top 10 Innovations by The Scientist

The Scientist magazine announced its top 10 new products selected by a panel of independent judges. The Lausanne-based start-up Nanolive…

MRM Debiopharm Challenge

MRM wins the Debiopharm – La Solution – Inartis Challenge

The 7th Debiopharm-La-Solution.ch-Inartis Challenge for the Quality of Life of Patient has rewarded with a prize of CHF 25’000 the…

4à6 BioAlps

VR training for new Lonza employees

How to attract and retain talented workers in the Biotech Industry? And how to train the new recruits efficiently? Lonza…

Innosuisse 2023

Innosuisse, what changes in 2023?

As of January 2023, Innosuisse is evolving. Grants will be distributed for international projects, and the financing of start-ups will…

Alliance TT

Alliance, your partner for your Innosuisse application

You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance…

Domo Health - Pépites

Domo Health: a digital platform for home health

Lack of resources and staff, aging population, an increase in chronic diseases: the challenges of the medical world are numerous…

Long Covid Syndrome

GeNeuro starts a clinical trials for its long COVID treatment

200 patients are recruited and will be followed in 5 Swiss hospitals participating in the study. The first results are…

Prof. Antoine Geissbuhler BioAlps President

Prof. Antoine Geissbuhler elected at the Royal Academy of Medicine of Belgium

A new mission for BioAlps’ President   Professor at the Department of Radiology and Medical Informatics of the Faculty of…

Symbios

Symbios opens a new factory in Yverdon

The 12 000 m2 facility will be ready next spring in the Y-Parc in Yverdon-les-Bains. Leader in the production of custom-made…

Volumina Medical

Volumina Medical Gets a CHF 500 000 Loan from FIT

Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of…

Switzerland sets to accept medical devices with FDA approval

The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate /…

ONWARD

EUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)

The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList….

Limula

Limula wins the start-up Swiss Technology Award

During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award.   Two other companies…

Cern et CHUV

CERN, CHUV and THERYQ develop a revolutionary FLASH radiotherapy device to fight cancer

This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with…

BioAlps Awards

Prof. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award.

The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of…

Dentsply Sirona

Dentsply Sirona wins the Vaud International Business Award

The dental products world leader employs 700 people in the canton.       Each fall, the Vaud International Business…

Obseva

ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million

The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in…

Opna bio

Opna Bio Raises $38M in Series A Financing

Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round…

nicollier

Claude Nicollier steps down from his position as CSEM

The former astronaut has spent 16 years as Chairperson of the Board of Directors   Effective June 2023, Claude Nicollier…

Novigenix

Novigenix announces first closing of its $20M Series B

The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient…

Neuria

Neuria receives the Start-Up Innovation Prize of the Canton of Fribourg

Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders  …

PeriVision

A CHF 1.6 million Innosuisse Grant for PeriVision

PeriVision was awarded an Innosuisse research grant together with the University Hospital Bern and ARTORG Center for Biomedical Engineering Research…

MICROCITY Neuchâtel, Land of Diagnostic

A Human lean Diagnostic programme in the canton of precision watchmaking   The historical heritage of high precision and core…

Domo Health Roche

Domo Health and Roche develop a digital health solution to detect the first signs of respiratory infections

Domo Health, a leader in digital health, announced the launch of its clinical study in collaboration with Roche Pharma Suisse…

Debiopharm Yona Link

Debiopharm leads $6M round for YonaLink to Scale Global Growth

The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and…

Neurorestore

Bone marrow neurons can be rewired to enable paraplegics to walk

Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system…

Dr. Sacha Pierre Sidjanski

Interview Sacha Sidjanski

Dr. Sacha Pierre Sidjanski is in charge of External Relations at the Faculty of Life Sciences at EPFL. He explains…

BioAlps Incyte

🔺4à6 BioAlps at Incyte🔺

  On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges.  …

Novochizol Alpha Chitin

Novochizol SA and Alpha Chitin Partner to Produce a Chitosan-Based Polysaccharide

Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products.   Alpha Chitin, a French biobased chemistry company…

Sofia Genetics Microsft

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure…

CSEM Dixi Polytool

Dixi Polytool wins CSEM’s Digital Journey Contest

The company will receive CHF 100,000 in technical support from CSEM to develop a smart factory and a 100% autonomous…

Prof Kalia

Interview Prof. Yogeshvar Kalia

Prof. Yogeshvar Kalia is Professor at the Faculty of Pharmaceutical Sciences at the University of Geneva (UNIGE) speaks about the…

Microbiome

How does the microbiota work?

Researchers at the University of Bern and University Hospital Bern have been able to comprehensively study the bacteria of the…

HUG Endotelix

A new test to avoid miscarriages and strokes

The HUG and the Unige have found a way to better detect the antibodies that cause thrombosis, which leads to…

MedAlliance

Cordis spends 1.14 billion francs to buy MedAlliance

Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis…

NeSensing

Netsensing Technology finalists of the 14th Healthcare Innovation World Cup at Medica 2022

Incubated at Microcity Neuchâtel, Netsensing Technology is excited to announce that it has been selected as one of the Top12…

Denis Cavin

Interview Denis Cavin

Why is Western Switzerland is a perfect place for lifesciences companies? Listen to Denis Cavin, Economic Development Officer at State of Geneva…

Oculis

Oculis to go public

The Lausanne-based company Oculis SA, and European Biotech Acquisition Corp, announced a business combination agreement to create a Nasdaq-listed biopharmaceutical…

Sun Bioscience

SUN Bioscience receives an EPFL Alumni Awards

The two co-founders of SUN bioscience received an EPFL Alumni Award, a price that distinguishes researchers over the course of…

La Source research programme

Improving the working conditions of health care workers

Collecte d’informations pour un projet de recherche HEIG-VD / Institut et Haute Ecole de Santé La Source – Conciliation vie privée vie professionnelle – TOUTES LES SOLUTIONS DE TOUS LES SECTEURS D’ACTIVITE SONT LES BIENVENUES

Firmenich

Firmenich inaugurates its new campus in Geneva

The 225,000 m2 site, located in the towns of Satigny and La Plaine, has a largely automated production capacity of…

Orama VR

ORamaVR raises 2.4M EUR in a post-seed funding round

The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the…

HealthCare Konnect

BoneView®, an AI solution to improve fractures diagnostic on X-rays images

Gleamer and HealthCare Konnect (HCK) partner to expand access to AI-Based double check-in fractures, effusions, dislocations and bone lesions on…

Ron Appel Christophe Dessimoz

Ron Appel, SIB’s president, retires

Bioinformatics pioneer gives way to the next generation   Ron Appel pioneered the field of bioinformatics in Switzerland and supported…

ArcoScreen and DAAV

ArcoScreen and DAAV are FIT

ArcoScreen and DAAV both receive a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). ArcoScreen…

Endometriosis

Progress in the diagnosis of endometriosis

Researchers from the University of Bern and Inselspital and University Hospital Bern, in collaboration with Australian scientists, are developing a…

Flowbone team

Flowbone SA concludes a CHF 2.1 million Seed round

The EPFL spin-off, active in the field of bone regeneration, prepares its US market entry.   “With aging population, fractures…

Unige Hepatite B

A UNIGE team reveals how Hepatitis B could be cured

The swiss🇨🇭 researchers have deciphered the precise functioning of a protective mechanism that could lead to a potential post-infection treatment…

Top 18 European Biotech startups

Four Swiss🇨🇭 start-ups in the Top 18 European TechBio companies

ONWARD, Haya Therapeutics, Retinai and Engimmune Therapeutics are in the top 18 Biotech companies in Europe according to investors. Stuck…

Volumina Medical

Volumina Medical closes its Series A funding to develop Adipearl

Clinique La Prairie and Skyviews Life Science Ltd are among the new investors   Volumina Medical, a spin-off from the…

Biopôle SA

Three new buildings on the Biopôle site in Lausanne

Biopôle SA announces a new partnership with Edmond de Rothschild Real Estate SICAV for the construction of three new buildings…

Fongit Fund

iOnctura, EBAMed and Terapet awarded by the Fongit

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has just announced the latest beneficiaries of the Fongit Innovation Fund (FIF). iOnctura…

Future of Health Grant

Future of Health: 10 digital healthcare start-ups awarded

EPFL Innovation Park and CSS present the 2022 cohort   The Future of Health Grant programme to support innovation in…

Nanolive

Nanolive SA closes a series C round at $22.2 million

After the successful closing of a US $22.2 million Series C equity financing, Nanolive announces the appointment of two extraordinary…

Hedera Dx

Hedera Dx raises €14 million in seed funding

The Swiss companies wants to accelerate the adoption of liquid biopsies for cancer testing   Swiss techbio company Hedera Dx,…

Incepto

Incepto raised €27 million

The platform for artificial intelligence solutions applied to medical imaging, announces a €27 million round of financing. The goal: to…

Onward Arm Injury

Onward Confirms Amazing Results to restore Arm and Hand Function in People With Spinal Cord Injury

The Up-LIFT study evaluating ARC-EX Therapy demonstrated the effectiveness of the device to improve extremity strength and function in people…

A year of Swiss biological and biomedical data science: SIB Swiss Institute of Bioinformatics

Discover some of the key highlights of the national organization for biological and biomedical data science in the SIB Profile 2022, our annual activity report. Together, our infrastructure solutions, expertise and interdisciplinary collaborations foster better science and healthcare, and give Switzerland a strong voice in global issues around life science data.

Selexis - Next Immune

Selexis and NexImmune Sign an Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers

This Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papillomavirus (HPV) associated tumors, and additional…

Debiopharm Whitelab Genomics

Debiopharm Innovation Funds invests to accelerate the development of genomics medicines via technology powered AI

The strategic investment arm of Swiss biopharmaceutical company Debiopharm wants to reduce biotherapies’ development time and cost using AI (Artificial…

Top 100 startups

Top 100 Swiss Startups 2022: the Life Sciences Winners

17 Western Switzerland Life Sciences startups in biotech, medtech and foodtech were selected   The TOP 100 Swiss Startup Award 2022…

Novartis 100 million investment

Novartis invests CHF 100 million in Basel

A new state-of-the-art biologics centre   Novartis announced plans to invest around CHF 100 million in the development of next-generation…

BCC Fribourg

New Gene Therapy Laboratory at the Biofactory Competence Center (BCC) in Fribourg

A jewel for biopharmaceutical education and research   The Biofactory Competence Center (BCC) in Freiburg inaugurated its new gene therapy…

Forum des 100

Forum des 100 – Le Temps

Two BioAlps experts nominated   Two Life Sciences experts, Dominique Truchot-Cardot and Alexandre Pauchard, are among the 100 personalities of…

machineMD

machineMD raises CHF 3.2 Million

T‍he MedTech startup is developing a medical device for the early diagnosis of neurological disorders including brain tumors via neuro-ophthalmic…

Chuv Trisomie 21

CHUV, HUG and Inserm help Down syndrome patients to get better

The injection of the hormone GnRH improved the cognitive functions of several Down syndrome patients   An Inserm team within…

AC Immune MJFOX

Parkinson’s Disease: AC Immune Receives a Grant from The Michael J. Fox Foundation

A new USD 0.5 million grant brings up to USD 3.7 million the total amount The Michael J. Fox Foundation…

Sensawear

A wearable tissue health monitor

Sensawear wins a CHF 150,000 Venture Kick grant to develop its wearable tissue health monitor   Sensawear has developed the…

SightIn Health

SightIn Health wins a CHF 150,000 Venture Kick grant

The Swiss start-up wants to develop an AI-SaaS to democratize the use and interpretation of ultrasound   SightIn Health’s Machine…

Day One Jura

DayOne Tech Accelerator presents its first cohort

The DayOne Tech Accelerator in the Canton of Jura has just announced its winners. Three Medtech startups are starting a…

AC Bioscience

AC BioScience closes a 4th seed-round of CHF 2.5 million

AC BioScience, a Biopôle-based clinical-stage biotech company pioneering the development of novel therapies in immuno-oncology and tumour vascular normalization, announces…

Alcon

Alcon buys Aerial Pharmaceutics for $770 million

Ophthalmic devices and Geneva-based Alcon has reached an agreement to acquire North Carolina-based Aerie Pharmaceuticals for $770 million (743.1 million…

Sandoz and Novartis

Novartis to list its subsidiary Sandoz on the stock exchange

Under consideration since 2021, the details of the demerger of Sandoz, the generic drug arm of Swiss pharmaceutical giant Novartis,…

Twiice

Twiice’s exoskeleton allows paralysed people to walk again

Vaud-based and EPFL spin-off startup TWIICE receives a CHF 100 000 seed loan from FIT   Every year, around 250,000…

Abionic

Abionic’s test diagnoses sepsis 3 days before the standards methods

Abionic’s test identifies in 5 minutes the earliest signs of sepsis 3 days before the standard of care. The technology…

Obseva

ObsEva plans job cuts

The ObsEva laboratory is to engage in a vast restructuring process in the face of difficulties encountered with the FDA…

Dexter Distalmotion

Dexter®, the Swiss surgery robot, makes its way to Germany

The Dexter® on-demand robotic surgery system created by the swiss company Distalmotion is now used by the Department for Women’s…

Debiopharm Unige

Debiopharm signs an new IDEAL agreement with the University of Geneva

Debiopharms and UNIGE want to fight together against cancer and drug-resistant bacterial infections JULY 25, 2022   Debiopharm, a Swiss…

Nano Decoder

Using proteins as barcodes to fight against counterfeiting

Nanodecoder, an EPFL spin-off, receives CHF 100 000 from FIT   The Fondation pour l’Innovation Technologique selection committee announced they…

Nestlé - Enterome

Nestlé Health Science invests EUR 40 million in Enterome

Nestlé Health Science has signed a collaboration agreement with French company Enterome to target food allergies and chronic intestinal diseases…

Nestlé & Perseo Pharma

Nestlé Health Science and Perseo Pharma partners to fight digestive diseases

Strategic collaboration to create therapies against digestive diseases   Perseo pharma, a preclinical stage biopharmaceutical company focused on breaking new…

ADC Therapeutics

ADC Therapeutics signs multi-million dollar licensing agreement with Sobi

The swiss and the Swedish companies partner for the development and commercialization of ZYNLONTA®, a drug for hematologic and solid…

Gnubiotics

Gnubiotics gets a CHF 1.4 million Innosuisse Grant

The biotech company evaluates the effects of glycopeptides on solid tumors   Gnubiotics Sciences, a biotech company pioneering the discovery…

b-ray Z

CHF 4 million for b-rayZ AG, a startup fighting breast cancer

The Tech4Eva alumni and University Hospital Zurich (USZ) uses AI for faster and better breast cancer diagnostics     b-RayZ AG…

Selexis - kbi

KBI Biopharma SA and Selexis SA inaugurated a new facility in Geneva

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development…

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l'Innovation Technologique (FIT)

The canton of Vaud keeps on backing the FIT

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l’Innovation Technologique (FIT)  …

Lonza, stein

Lonza opens a new production facility in Stein (CH)

Lonza plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH). CHF 500 million will…

Vaud Investments Life Sciences

Vaud invests CHF 178 Million in Life Sciences

To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne…

CSEM and Clexbio Team

Supervene: growing humain vein tissues

ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins…

Magali Bischof, Secretary General of BioAlps (L) with George Kouvas Chief Technology Officer at the Wyss Center (R)

Wyss Center joins life sciences cluster BioAlps 

The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives,…

Madiha Derouazi (right) and Elodie Belnoue (left)

Geneva researcher wins European Inventor’s Award

Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded…

ten23health

ten23health is building a new facility in Visp

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a…

Ecotope 1

Ecotope, the new EPFL Innovation Park’s project

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together…

ORama VR

A CHF 12 Million Innosuisse Grant for a VR Surgical Training Method

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A….

Limula wins a prestigious EIC grant of €4.7 million

By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.

AlveoliX Swiss Medtech Award

AlveoliX wins the Swiss Medtech Award 2022

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019,…

Solange Peters Chuv

CHUV strengthens its strategy to fight cancer

The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The…

BioAlps OM Pharma 4à6

BioAlps at OM Pharma

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma…

Cityva 3D

Cytiva opens a new production site in Grens (VD)

Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022.   The site will manufacture…

Top Swiss Startups

Votes are open for the TOP 100 Swiss Startups! 

What is your favorite swiss startup?   Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative…

Prof. Antoine Geissbuhler BioAlps President

Pr. Antoine Geissbuhler is the new BioAlps’ President

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster…

Alithea Genomics

Alithea Genomics closes a CHF 1 million seed round

Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of…

Dr. Andrea Pfeifer Ac Immune SA

Dr. Andrea Pfeifer received the Aenne Burda Award

The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease  …

Kodiak Sciences and Lonza open a new facility in Visp

Kodiak Sciences and Lonza open a new facility in Visp

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases,…

Spark centre for movement science and technologies

SpArk, the centre for movement science and technologies, is born!

This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The…

Hansjorg Wyss

Hansjörg Wyss, the life sciences philanthropist

On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great…

Onward 1

ONWARD’s Neurostimulator Restores Mobility for Patients with Spinal Cord Injury

This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the…

HemostOD

HemostOD creates ex vivo blood platelets

HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100…

Biotech

Swiss biotech companies attracted investments of $3.33 billion in 2021

Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited…

Claude Clément

Podcast: Claude Clément

BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do…

Debiotech

A revolutionary home dialysis device made in Switzerland

The VersiTMPD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance

Merck Serono Christophe Martin

Merck Serono improves quality control with IA

Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit   In any factory,…

Limula Ceidos Stemmatters

EUR 1 million Eurostars grant for Limula and Ceidos

The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14…

startup invest

Switzerland is high on the financing of medical startups

Switzerland ranks fourth in Europe in terms of the number of deals behind Britain, Germany and France.   Last year,…

Plair SA raised CHF 2,7 million

A grant to fund the Rapid-C Real-Time Microbial Detector    Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF…

Artiria Medical

Artiria Medical raised CHF 3.8 million to improve stroke treatment

Artiria Medical, a swiss neurovascular start-up, raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective…

Neuro Restore

An electronic implant helps a bedridden patient to walk again

Researchers at the NeuroRestore research center in Lausanne Switzerland helped a patient suffering from a neurogenerative disease to leave her…

Neurosoft Bioelectronics

Neurosoft Bioelectronics raised CHF 3 Million

The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain   Neurosoft Bioelectronics, an early-stage…

Western Switzerland, paradise for Life Sciences Companies

18 new foreign life sciences companies settled in our region in 2021   Last year, according to GGBa’s annual report,…

Tech4Eva

Tech4Eva 2022 cohort

13 growth-stage startups and 15 early-stage start-ups and projects have been selected for the 2022 program.   Tech4Eva is an…

Nanolive raises US $ 20 million

The Swiss company is a pioneer in the development of live-cell imaging, and digital analytical solutions The swiss leading live-cell…

Venturelab Medtech Team 2022

Venture Leaders Medtech Team 2022

Ten startups have been chosen by a jury of investors as the Swiss National Startup Team for Venture Leaders Medtech…

MEC at Campus Biotech

A MEG plateform at Campus Biotech in 2022

A new device for brain research at the Campus Biotech   Next summer, the Human Neuroscience Platform (HNP) at Campus…

Wyss Center

Completely locked-in man uses brain-computer interface to communicate

Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals   Completely paralyzed…

Ana Pinto

INTERVIEW – Ana Pinto

🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie…

Parithera Device

Parithera raises CHF 100 000 from FIT

The Foundation for Technological Innovation (FIT) has granted a CHF 100’000 Tech Seed loan to Parithera and its ExTrace Dx…

Nagi Bioscience

Nagi Bioscience won a € 2,5 million grant from the EIC Accelerator

The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology   Nagi Bioscience has been bestowed the prestigious and highly…

Swiss Medtech Ukraine

Medical devices for Ukraine

The Ukraine Embassy launches an appeal for donations   Collection points in Switzerland The war in Ukraine has thrown millions…

SEED Biosciences raises CHF 400 000

The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one.   The device, called…

Parkinson Disease

A gene could prevent Parkinson’s disease

A mutation in the Fer2 gene causes motor deficiencies in flies   The laboratory of Emi Nagoshi, Professor in the…

Monthey BioArk

BioArk Monthey is expanding

A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first…

Ceidos Founders

Ceidos revolutionises cell culture

The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that…

Superlab Lausanne

Superlab Suisse Lausanne

A coworking space designed for scientists   Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in…

Unige breast Cancer

UNIGE: Fighting breast cancer cells growth

A low rate of a specific protein triggers tumors development. A UNIGE team found the counter-attack   In about 2/3…

Li Tang CEO Leman Biotech EPFL

$11 million for EPFL spin-off Leman Biotech

A protein that boosts the immune system can cure 90% of cancer in mice   Immunotherapy, which aims to boost…

GSK Haleon

GSK’s new company Haleon will have a site in Nyon

The pharmaceutical group GlaxoSmithKline creates Haleon, a new company from the separation of its consumer healthcare business. This entity will…

Neo Medical

Neo Medical raises $20 million for its AR technology for spine surgery

Swisscom Ventures is the lead investor in this round. The Vaud-based company will use the new funds to accelerate the…

Massimo Nobile

INTERVIEW : Massimo Nobile

🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.

MindMaze

MindMaze secures a $105 million financing round

After a banner-year, the Lausanne-based company MindMaze secures $105 Million Financing, led by Concord Health Partners, and initiates American Hospital…

Leucine Project

Leucine project: a new hub for life sciences in Lausanne

New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new…

Carrol-Plummer-and-Nigel-Wallbridge

PhytlSigns raises CHF 500 000 for a plant monitoring system

The ‘Fitbit of Plants’ uses AI sensors to monitor crops   The startup Vivent provides growers with a technology to…

Miniature Raphaël Conz

INTERVIEW : Raphaël Conz, BioAlps vice-president

🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of…

Animal Testing

Swiss voters reject ban on animal testing

Voters have rejected a complete ban on experiments on living creatures in Switzerland.   The idea of putting an end…

Adaptyv Biosystems

Adaptyv Biosystems raised CHF 2.5 million in a pre-seed funding

Adaptyv Biosystems is to create the world’s largest protein design database   The company, based in Biopôle in Epalinges, is…

Genolier Innovation Hub

Genolier Innovation Hub

A new medical Innovation Hub will open in 2024   “This is not a real estate project to house the…

Haya Therapeutics

Haya Therapeuthics closes US$ 5 Million seed extension

The Lausanne-based company will open a branch office in San Diego to continue its growth   HAYA closes US$ 5…

Miniature Claude Clément

INTERVIEW : Claude Clément, BioAlps President

  🔺 Claude Clément is BioAlps President. According to him, multiculturality is why Switzerland🇨🇭 has become so successful in the…

Science first, politics second

The “Stick to Science” petition aims to allow Swiss and British researchers to remain in Horizon Europe programme.   The…

.NeuroRestore

An implant could cure paralysis

A new implant enables patients with a complete spinal cord injury to stand, walk and even swim    Michel Roccati,…

La Source

La Source Launches H4

La Source opens an innovation platform dedicated to care and health in Vaud (Switzerland).   The H4 “Hands-on Human Health…

Distalmotion

Distalmotion | $ 90M to make sense of robotic surgery

A partnership of medtech pioneers and company-builders   Distalmotion, based in Lausanne (Switzerland), Revival Healthcare Capital and 415 CAPITAL announced…

Takeda

Takeda | New building in Neuchâtel estimated at CHF 30 million

The pharmaceutical group Takeda wishes to increase the production capacity of its site in Neuchâtel (Switzerland) and will build a…

ADC Therapeutics

ADC Therapeutics | $30 million in new partnership deal

Development & commercialisation of ZYNLONTA in Japan   ADC Therapeutics SA, a commercial-stage biotechnology company improving the lives of those…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the newest resources in SIB’s infrastructure portfolio for the Life Sciences

Development of national secure platforms, leading open science databases & software tools    The Swiss Institute of Bioinformatics (SIB)’s mission,…

Antio Biosciences

Antion Biosciences | Exclusive collaboration & global license agreement with Allogene Therapeutics

Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products…

Adiposs SA

Adiposs | Raised CHF 1.8M 1st closing of its Pre-Series A round

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for…

Venture Kick

Record-high startup support for Swiss university spin-offs in 2022

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841…

Magali Bischof

Magali Bischof to become the new General Secretary of BioAlps

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs…

GeNeuro

GeNeuro | CHF 6.7 million for the development of COVID-19 medicines

GeNeuro received CHF 6.7 million in funding for the development of temelimab against Long-COVID   GeNeuro, a biopharmaceutical company developing…

Merck & Chord Therapeutics

Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics

Merck invests into Cadribine to try to cure rare neuroinflammatory diseases   Chord Therapeutics (Chord), a clinical-stage biopharmaceutical company developing…

Xsensio

Xsensio | CHF 4.2 million to accelerate market launch

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the…

D36.ch

Intellias and D36.ch join forces

In November 2021, Intellias, a technology partner of Fortune 500 companies and top-tier organizations, and D36.ch, an innovative Swiss healthcare startup, announced their strategic partnership. The companies are joining efforts to build a bridge between the Swiss digital health market and world-class IT services to reinforce customers’ digital strength by combining 360-degree domain expertise with state-of-the-art software engineering solutions.

Biopôle SA

Biopôle | Partnership programme with Swiss Medical Network

Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private…

Sun genomics

Sun Genomics | Sets up European subsidiary in Fribourg (Switzerland)

1st establishment of a US company in Western Switzerland without prior in-person meeting   A first for the canton of…

Heidi.news | BioAlps: 20 years of innovation

Medical innovation & contribution to the future of medicine   On 30 November, 2021, Mrs Annick Chevillot (Heidi.news) has moderated…

HEIG-VD

Appointment of a new Full Professor at HEIG-VD

Underlines the ambition of the HEIG-VD to pursue its development in management applied to the health sector, both in the field of education and research

HealthCare Konnect

Deep Bio and HealthCare Konnect | Improving cancer diagnosis

Deep Bio and HealthCare Konnect (HCK) partner to improve cancer diagnosis in Switzerland and North Africa   On 18 October…

OM Pharma

BioAlps | 20 years of innovation | OM Pharma

Investing, innovating and hiring in Switzerland to prevent infection worldwide   We are pleased to share with you our new…

Debiopharm

BioAlps | 20 years of innovation | Debiopharm

Debiopharm | We develop for patients   We are pleased to share with you our new testimonial series as part…

Ichnos

BioAlps | 20 years of innovation | Ichnos

Developing first-in-class bi-/trispecific antibodies to treat cancer patients   We are pleased to share with you our new testimonial series…

Swiss Pathogen Surveillance Platform

Creation of the Swiss Pathogen Surveillance Platform SPSP

Switzerland establishes a national infrastructure to track COVID-19 and its variants Discover the role of the Swiss Pathogen Surveillance Platform…

Pharmalp

BioAlps | 20 years of innovation | Pharmalp

Developing and distributing efficacious natural healthcare products   We are pleased to share with you our new testimonial series as…

CSL

BioAlps | 20 years of innovation | CSL Behring

Fast-tracking innovation through long-term mutual partnerships with academia   We are pleased to share with you our new testimonial series…

Vifor Pharma

BioAlps | 20 years of innovation | Vifor Pharma

On a mission to help patients live better, healthier lives   We are pleased to share with you our new…

BioArk

BioAlps | 20 years of innovation | BioArk

Strengthening the Life Sciences value chain from discovery to market   We are pleased to share with you our new…

HES-SO

BioAlps | 20 years of innovation | HES-SO

Supporting the Swiss economy with locally rooted training and applied research   We are pleased to share with you our…

Selexis

BioAlps | 20 years of innovation | Selexis

Selexis | Cell line development meets lab automation and robotics for biologic therapeutic manufacturing   We are pleased to share…

Fongit

BioAlps | 20 years of innovation | Fongit

Fongit | Switzerland’s premier startup incubator   We are pleased to share with you our new testimonial series as part…

SILAB

BioAlps | 20 years of innovation | SILAB

SILAB ǀ Dedicated to promoting a relevant and sustainable innovation in healthcare   We are pleased to share with you…

UNIL

BioAlps | 20 years of innovation | UNIL

UNIL | A commitment to transforming Life Sciences into concrete actions for the benefit of all   We are pleased…

CERN

BioAlps | 20 years of innovation | CERN

CERN | Unique technologies with a wide scope of applications   We are pleased to share with you our new…

Netsensing

BioAlps | 20 years of innovation | Netsensing

Netsensing | Saving lives through the detection of sleep apnea   We are pleased to share with you our new…

JAG

BioAlps | 20 years of innovation | JAG

JAG | Highly automated process plants for the pharmaceutical and biotech industries   We are pleased to share with you…

GGBa

BioAlps | 20 years of innovation | Greater Geneva Bern area

GGBa | The official investment promotion agency for Western Switzerland   We are pleased to share with you our new…

Gnubiotics

BioAlps | 20 years of innovation | Gnubiotics

Gnubiotics | Novel microbiome health solutions   We are pleased to share with you our new testimonial series as part…

GeNeuro

BioAlps | 20 years of innovation | GeNeuro

Fighting against neurodegenerative and autoimmune disease with antibodies   We are pleased to share with you our new testimonial series…

Neurix

BioAlps | 20 years of innovation | Neurix

Minibrain technology enabling efficient drug testing and development   We are pleased to share with you our new testimonial series…

Coat-X

BioAlps | 20 years of innovation | Coat-X

Thin-film encapsulation technology helping increase product reliability and miniaturisation effectiveness   We are pleased to share with you our new…

UCB

BioAlps | 20 years of innovation | UCB

UCB | Creating value for patients now and into the future   We are pleased to share with you our…

EPFL

EPFL | Research with animals

A necessity for scientific progress   Despite the many advancements in developing innovative alternative methods, animal testing still plays an…

Swiss Biotech Association

BioAlps | 20 years of innovation | Swiss Biotech Association

SBA | Representing the interests of the Swiss biotech industry   We are pleased to share with you our new…

Socorex

BioAlps | 20 years of innovation | Socorex

60 years of high-quality manufacturing of liquid handling instruments   We are pleased to share with you our new testimonial…

Debiotech

BioAlps | 20 years of innovation | Debiotech

Key medtech player fostering innovative medical software solutions and device development projects   We are pleased to share with you…

Biopôle

BioAlps | 20 years of innovation | Biopôle

High-quality support and valuable community for life sciences companies   We are pleased to share with you our new testimonial…

KATZAROV

BioAlps | 20 years of innovation | KATZAROV

Intellectual property for Life Sciences innovators   We are pleased to share with you our new testimonial series as part…

Incyte Bioplant

New Incyte bioplant opens in Switzerland

Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud   On 31 August 2021, Incyte, the US-based…

CSEM

BioAlps | 20 years of innovation | CSEM

Supporting the Life Sciences industry with cell-tech, biomonitoring and lab automation know-how   We are pleased to share with you…

iOnctura

BioAlps | 20 years of innovation | iOnctura

iOnctura | Better drugs to beat cancer resistance   We are pleased to share with you our new testimonial series…

Combioxin SA

Combioxin signs a worldwide licensing agreement

Combioxin has signed a worldwide licensing agreement with Eagle Pharmaceuticals Eagle Pharmaceuticals has entered into a worldwide licensing agreement with…

AC Immune

BioAlps | 20 years of innovation | AC Immune

Addressing the slow pandemic of neurodegenerative diseases   We are pleased to share with you our new testimonial series as…

Innovaud

BioAlps | 20 years of innovation | Innovaud

Connecting tech-oriented companies | Supporting cross-cutting innovation   We are pleased to share with you our new testimonial series as…

Geneus

BioAlps | 20 years of innovation | Geneus

Life Sciences innovation initiator | Transforming ideas & research into startups   We are pleased to share with you our…

SIB Swiss Institute of Bioinformatics

BioAlps | 20 years of innovation | SIB Swiss Institute of Bioinformatics

SIB | Supporting the Life Sciences community with Computational Biology and Bioinformatics know-how   We are pleased to share with…

Abionic

BioAlps | 20 years of innovation | Abionic

Nanotechnology to detect sepsis in 5 minutes from one drop of blood   We are pleased to share with you…

HEPIA Tissue Engineering Lab

BioAlps | 20 years of innovation | HEPIA Tissue Engineering Lab

Microtech tools meet novel integrated in vitro cellular model to help accelerate research    We are pleased to share with…

Lunaphore

Lunaphore | Top 10 Spatial Biology Companies

Lunaphore was selected as one of the top 10 spatial biology companies in the world   Lunaphore Technologies has been…

Fongit

FONGIT Innovation Fund selects four startups

FIF | FONGIT Innovation Fund Following the announcement of the creation of the FONGIT Innovation Fund (FIF), the foundation supporting…

Distalmotion

Distalmotion | Pioneering Hybrid Robotics in General Surgery

CHUV performed the world’s first hybrid robotic general surgery   Distalmotion & CHUV announced the successful start to a case series…

EBAMed

EBAMed | Prospective Imaging Study

First patient enrollment   EBAMed announced first patient enrolled in prospective imaging study with ultrasound guidance prototype in ventricular tachycardia…

SOPHiA GENETICS | Opts for Nasdaq IPO

Closing of $234 mio. Initial Public Offering & $20 mio. Private Placement   SOPHiA GENETICS SA (Nasdaq: SOPH), the creator…

Oncology

CHUV | A breakthrough in oncology

CHUV | Biomarkers which could save lives   Scientists at CHUV have identified cells which create metastasis in a tumour….

Merck

Merck | New Biotech Development Center

Merck reaches key milestone in the construction of its Biotech Development Center Announced in January 2020, Merck‘s new state-of-the-art biotech development…

Asceneuron

Asceneuron | Appoints new Board Member

Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases

Drug Discovery World

Drug Discovery World | Switzerland as a global biotech hub

Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued…

AC Biosciences

AC BioScience | Committed to fight against cancer

Interview with Andreas Schläpfer, CEO & cofounder   AC BioScience, the Vaud based company is a pioneer in the development…

EPFL

EPFL | A virus to identify small peptide mimics of antifreeze proteins

Scientists at EPFL (Polymers Laboratory) and the University of Warwick have used a virus to identify a peptide that can…

EPFL

EPFL | Next-generation implants will be biodegradable and non-invasive

Tissue grows back once the implant is gone   EPFL engineers have developed a neural interface that disappears harmlessly in…

CSEM

CSEM | Solid 2020 results despite the tough economic climate

Digital support to Gait Up    CSEM posted a solid financial performance in 2020 and made further progress on important technological…

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund | 1st venture fund dedicated to diabetes technology

CHF 50 million for diabetes ventures Launch of the first venture fund dedicated to diabetes technology, through a collaboration between…

UNIGE

UNIGE | How do immune cells get activated?

Decoding the activation mechanism of the CCR5 receptor By studying the structure of cellular receptors and of the molecules that…

EPFL

EPFL | Tailored optical stimulation for the blind

Stimulation of the nervous system with neurotechnology EPFL scientists in a European collaboration propose a personalised protocol for optimising stimulation…

CERN

CERN | CLEAR study paves the way for novel electron-based cancer therapy

High-energy electron beams can be focused onto deep-seated cancerous tumours   The study, conducted at CERN’s CLEAR test facility, demonstrates…

PharmaPlan

Pharmaplan (TTP Group) | New office in Visp close to Lonza

New office with 60 employees   In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another…

LABIOTECH.EU

Top 15 Swiss biotech startups making a difference in Europe

This article was written by Labiotech.eu with the support of BioAlps, the Greater Zurich Area, and Switzerland Global Enterprise (S-GE)….

Fondation Leenaards

Leenaards Foundation | Science Prize 2021

CHF 1.4 mio for biomedical research in the Lake Geneva region   The Leenaards Foundation has awarded Science Prizes to…

HEIG VD

HEIG VD | Rethinking the manufacture of cell & gene therapies

  HEIG-VD is joining forces with the EPFL and the University of Geneva (UNIGE) to take up the challenge of…

Embion

Embion | Nominated for the Swiss Economic Award 2021

The most important prize for young entrepreneurs in Switzerland   From dozens of applications, nine companies were nominated for the…

EPFL

EPFL | How healthy is your digital twin?

Ethical & legal questions   Digital twins – a savvy combination of artificial intelligence and personal data – have already…

Venturelab

Venturelab | Venture Leaders Medtech 2021

Meet the Swiss national MedTech team   The Swiss National Startup Team has 10 new members: 10 startups were selected…

Abologix

Abologix | Wins CHF 150,000

Sum used to develop targeted antibodies for cancer patients   Abologix develops a new therapeutic option to treat lymphoma patients…

Rheon Medical

Rheon Medical | 1st implantation of the “Eyewatch” implant in Valais

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited…

UNIGE

UNIGE | Replicating patients’ tumours to test different treatments

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour…

GGBa

GGBa | Geneva welcomes new global health investment advisory

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva…

EarlySight

EarlySight | Seed round closing

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million…

Selexis

Selexis | “Best Workplaces™ Switzerland” 2021

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that…

Heidi.news

Heidi.news | The Swiss Confederation reinvests in the development of Swiss vaccines

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research…

Switzerland Global Enterprise

S-GE | The new EU Medical Device Regulation (MDR) came into force on 26 May 2021

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date…

Haya Therapeutics

Haya Therapeutics | Completes CHF 18 mio. seed financing

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific…

CERN

CERN | Innovate in healthcare with CERN

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT)…

Biopôle

Biopôle | New start-up fund to foster early innovation in the Life Sciences

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes…

EPFL

EPFL | Cancer cells hijack the 3D structure of DNA

A novel algorithmic approach on cancer cells   Scientists at EPFL and UNIL have used a novel algorithmic approach on…

bNovate

bNovate | Fundraising to expand commercial activities internationally

CHF 5 million fundraising bNovate Technologies SA, a Swiss company specialised in industrial microbiology aiming at increasing the safety of…

Flowbone

Flowbone | Winner of the 2nd round of the Venture Kick competition

Prize of CHF 50’000   EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The scientists…

Lonza

Lonza | Invests CHF 650 million in Visp

Significant investments to expand its mammalian drug substance manufacturing facilities in Visp The Lonza‘s expansion in Visp (Valais, Switzerland) will…

Swiss Biotech Center

Swiss Biotech Center | Covid-19: a 2nd generation vaccine in preparation in Monthey

Strategic collaboration agreement between Swiss Biotech Center & Berna Biotech Pharma The Swiss biotech companies Berna Biotech Pharma Gmbh and…

Alithea Genomics

Alithea Genomics | Has been awarded CHF 150,000

CHF 150,000 for RNA sequencing to boost biomedical research Lausanne-based Alithea Genomics, developing a novel technology that enables a high…

Debiopharm

Debiopharm | Launch of the “Innovation DEbiopharm Academia Léman” (IDEAL)

The Lemanic region as a hub for Life Science innovation   Debiopharm a Swiss biopharmaceutical company based in Lausanne, announced the…

Calciscon

Calciscon | Raised CHF 2.5M Series A

Commercialisation of the T50 Test to drive more efficient therapies for renal patients    Calciscon AG announced  the closing for…

Gondola Medical Technologies

Gondola Medical Technologies | New research momentum

Building clinical research momentum with 500’000 CHF Tech Growth loan Clinical research and studies demonstrate Gondola Medical Technologies AMPS therapy’s…

EPFL

EPFL | New “brain stress test” for evaluating the mental status of patients with Parkinson’s disease

Awakening “ghosts” in patients with Parkinson’s   EPFL scientists are developing a completely new “brain stress test” for evaluating the…

HCK

Healthcare Konnect (HCK) | Distribution agreement signed with VUNO

Introduction of AI suite in Swiss medical institutions   South Korean Medical AI trailblazer, VUNO, and Swiss medical distribution company,…

Biopôle

Biopôle | Neurotechnologies offer new hope for patients with Parkinson’s disease

3 Biopôle-based companies are striving to find innovation solutions   CHUV-NeuroTech, ND BioSciences & Gondola Medical Technologies , 3 Biopôle-based companies are…

Mybiopassport

CoreMedica Europe | Intercantonal collaboration on SARS-COV-2 detection in saliva 

Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method   CoreMedica Europe a Swiss biotechnology company based…

HEIG VD

HEIG – VD | Innovations in health care

A brand new tool is available to map the organisational impacts    Innovation in health care is shaking up and…

ADC Therapeutics

ADC Therapeutics | FDA Approval of ZYNLONTA™

FDA Approval of ZYNLONTA™ in Relapsed or Refractory Diffuse Large B-Cell Lymphoma   ADC Therapeutics SA announced that the Food…

Swiss Biotech Association

Swiss Biotech Association | Record year for Western Switzerland’s biotech industry

An attractive, dynamic & ever-growing life sciences ecosystem   Biotechnology companies based in Switzerland have experienced record investments in the…

EPFL

EPFL | New hydrogel can repair tears in human tissue

An injectable gel that can attach to various kinds of soft internal tissues    EPFL scientists have developed an injectable…

Ferring

Ferring Pharmaceuticals | Ferring Biologics Innovation Centre opens at Biopôle

A new hub for biologics R&D in Western Switzerland   On 1 April 2021, the research-driven biopharmaceutical group Ferring Pharmaceuticals…

GGBa

GGBa | 85 new foreign companies in Western Switzerland in 2020

In 2020, 85 new foreign companies set up shop in Western Switzerland, supported by Greater Geneva Bern area (GGBa) and the…

Lonza

Lonza | Hiring of 1200 people in Visp

Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the SIB Remarkable Outputs 2020

Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.

CSEM

CSEM | 2020 Digital Journey Award

Gait Up & Definition12 win the 2020 CSEM digital journey award   CSEM has announced the two winners of its…

SIB Swiss Bioinformatics Institute

SIB | Creation of a Swiss SARS-CoV-2 Data Hub 

Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub  Over the past weeks and with the threat of emerging…

Inait

Inait | Joined the Scale Up Vaud program

Artificial Brain Intelligence (ABI)   An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud…

Netsensing Technology

Netsensing Technology | SmartEEs2 (EU H2020) contracting phase

The EU consortium will reinforce its penetration to global market & its position with EU partners   Incubated at Microcity,…

Terapet

Terapet | Proton therapy

CHF 1.5M of non-dilutive funding   Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer,…

Adiposs

Adiposs | Green light for clinical trials

ImageBAT   Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK,  the Geneva…

CHUV HUG EPFL

CHUV, EPFL, HUG | AI now sees & hears COVID in your lungs

Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds   DeepChest…

Asceneuron

Asceneuron SA | Awarded by the Alzheimer’s Drug Discovery Foundation

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021

Biopôle

Biopôle | Hosts the 1st branch of Superlab Suisse

The centre will open by the end of the 2nd quarter of 2021   Superlab Suisse AG, a Zurich-based private…

EBAMed

EBAMed | Swiss-based medtech startup

New CEO   EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist…

Biopôle

Biopôle | 3 new buildings by 2024

Life Sciences cluster   The Biopôle site continues its strong development with the construction of three new buildings. By 2024,…

Canton Neuchâtel

New training course: chemical & pharmaceutical production technologist

Close collaboration between biopharmaceutical companies & Canton de Neuchâtel   The Canton of Neuchâtel will open up a new dual-mode training route…

Universität Bern

Bern Center for Artificial Intelligence in Medicine (CAIM)

A new platform in the field of Artificial Intelligence in medicine   The University of Bern & the Inselspital, Bern…

Universität Bern

Multidisciplinary Center for Infectious Diseases & Immunity (MCIDI)

Newly founded: MCIDI   The University of Bern established a multidisciplinary center to study the origin and course of infectious…

Zeta

ZETA | A new subsidiary in Switzerland (Visp, VS)

Switzerland is the Mecca of the pharmaceutical industry   ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages…

Distalmotion

Distalmotion | Received European CE mark for Dexter surgical robot

Dexter surgical robot  Distalmotion, a Swiss-based medical device company establishing a new global standard of care ensuring every patient can…

Debiopharm

Debiopharm | Phase II research against covid-19 launched

Antiviral Alisporivir: a valuable additional therapy to SOC   Debiopharm, a Swiss biopharmaceutical company, announced the first patient dosed in…

ADR-AC | A new testing service against the new Coronavirus 2019

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Swiss Medtech

Swiss Medtech | Award 2021

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL

EPFL | New synthetic molecule to kill the flu virus

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

EspeRare Pierre Fabre

EspeRare & Pierre Fabre | A pioneering treatment for XLHED

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Comphya

Comphya | Raised additional USD 1.3 million

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

ABCDx

ABCDx | Submit StrokeCheck for clearance in the US & EU

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

Lymphatica

Lymphatica Medtech | Raises seven-digit Series A round

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

SICHH

SICHH | BrainFit4Life project

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

Biopôle CSL Behring

CSL BEHRING REI & BIOPÔLE | A new collaboration partnership

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

Abionic

Abionic | Five-minutes test for scoring COVID-19 severity

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

HESAV Campus Santé

HESAV | A new Campus dedicated to Health

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

SEED Biosciences

SEED Biosciences | Completes CHF 1 mio. series A financing round

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…

Eyeware

Startup Eyeware | Products available all the way to Japan!

Eyeware has just entered into a partnership with the company Studio Uni    The startup Eyeware, hosted at IdeArk in…

Netsensing Technology

Netsensing Technology | Raised funds for it Home Sleep Apnea Test (HSAT)

Netsensing Technology secures a seed financing round to accelerate Home Sleep Apnea Test device development   Netsensing Technology Sàrl has…

COVID-19

SICHH | “Connect People with Science” platform

A new scientific communication platform   A new scientific communication platform entitled “Connect People with Science” is being launched. Its…

JSR Life Sciences

JSR | Expands its European Gene-to-GMP in Geneva

Geneva: 250 new highly technical jobs   JSR Life Sciences, LLC announced that it is increasing its European footprint with…

Plair SA MBV

Plair SA – MBV | Signature of a collaboration agreement

Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and…

EPFL

COVID-19 Testimonial Series | Laboratory of Biological Network Characterization (LBNC)

Next generation microfluidic devices for applications in molecular diagnostics   The following article is part of BioAlps’ testimonial series and…

Technology by Bilan 2020

Technology by Bilan 2020

Revolution in Healthcare | How robotics, virtual reality and artificial intelligence are improving the profession   Bilan, in partnership with…

EPFL

COVID-19 Testimonial Series | EPFL’s Laboratory of Microbiology and Microtechnology

Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments   The following article is part of BioAlps’…

CSL Behring

CSL Behring | Opening of a new manufacturing facility in Bern (Switzerland)

To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern   The new…

MaxiVAX

COVID-19 Testimonial Series | MaxiVAX

The Geneva-based immune-oncology startup contributing to the SARS-CoV-2 vaccine development   The following article is part of BioAlps’ testimonial series…

Sophia Genetics

SOPHiA GENETICS raises $110 million in oversubscribed new funding round

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine   SOPHiA GENETICS, global leader…

GaDia

COVID-19 Testimonial Series | GaDia

A rapid diagnostic test for the detection of antibodies against COVID-19   The following article is part of BioAlps’ testimonial…

Coronasense

COVID-19 Testimonial Series | Coronasense

A device capable of autonomously screening the body temperature to detect fever symptoms caused by viral or bacterial infections  …

CERN

COVID-19 Testimonial Series | CERN

Leveraging CERN’s novel technologies and know-how to develop health applications   The following article is part of BioAlps’ testimonial series…

SwissCovid

COVID-19 Testimonial Series | SwissCovid

SwissCovid app | Privacy by design   The following article is part of BioAlps’ testimonial series and was written by…

Takeda

COVID-19 Testimonial Series | Takeda Neuchâtel Manufacturing Site

Reorganisation of teams and work streams to ensure the production and delivery of life-saving products while protecting the health of…

HUG

COVID-19 Testimonial Series | HUG Innovation Center

Digital solutions, fundamental and clinical research, and organisational process redesign to support the fight against COVID and enhance the physicians-patients…

JAG

COVID-19 Testimonial Series | JAG Process Solutions

Development of vaccine, drugs and robotic disinfection equipment to fight COVID-19   The following article is part of BioAlps’ testimonial…

EBAMed

EBAMed annonces EUR 2.4 million grant

EBAMed receives a EUR 2.4 million grant from the EU Horizon 2020 Research and Innovation Program   EBAMed is glad…

SwissKH

COVID-19 Testimonial Series | SwissKH

Swiss-made protective visor and door opening device to protect against COVID-19   The following article is part of BioAlps’ testimonial…

Vaccine Formulation Institute (VFI)

COVID-19 Testimonial Series | Vaccine Formulation Institute (VFI)

Open-access adjuvants and vaccine formulation expertise to benefit the whole community in the fight against COVID-19   The following article…

Aquanetto

COVID-19 Testimonial Series | AquaNetto

Fluid and surface disinfection sustainable modular solutions to fight against COVID-19   The following article is part of BioAlps’ testimonial…

UCB

COVID-19 Testimonial Series | UCB

Supporting patients, healthcare providers and communities worldwide through treatment and vaccine research, testing resources and donations   The following article…

Neurix

COVID-19 Testimonial Series | Neurix SA

A Swiss in vitro drug testing platform for the identification of potential treatments against coronavirus   The following article is…

UNIGE Biopharmaceutics

COVID-19 Testimonial Series | UNIGE Biopharmaceutics

Development of mRNA and DNA vaccines against COVID-19   The following article is part of BioAlps’ testimonial series and was…

Spentys

COVID-19 Testimonial Series | Spentys

High-quality 3D scanning, modelling, and printing solutions for healthcare providers   The following article is part of BioAlps’ testimonial series…

Norgren

COVID-19 Testimonial Series | Norgren (FAS)

Swiss manufacturer of liquid valves, syringe pumps and mass flow controllers supporting the high-level of demand in ventilators   The…

Combioxin SA

COVID-19 Testimonial Series | Combioxin SA

First-in-class life-saving drugs for severe infections   The following article is part of BioAlps’ testimonial series and was written by…

Helvetica Health Care

COVID-19 Testimonial Series | Helvetica Health Care

Marketing and distribution of a wide range of molecular controls and panels   The following article is part of BioAlps’…

PICC Solution

COVID-19 Testimonial Series | PICC Solution

How AI can support research by extracting, analysing and compiling data The following article is part of BioAlps’ testimonial series…

Embedded Systems Laboratory

COVID-19 Testimonial Series | Coughvid

How AI applied to cough recordings can help in the identification of COVID-19 cases   The following article is part…

Distillery Morand

COVID-19 Testimonial Series | Morand Distillery

From spirit production to hand sanitisers   The following article is part of BioAlps’ testimonial series and was written by…

SICHH

COVID-19 Testimonial Series | Swiss Integrative Center for Human Health (SICHH)

Adapting to become a satellite laboratory to carry out genetic testing of SARS-Cov-2 for the Fribourg Hospital (HFR)   The…

Daphne Technology

COVID-19 Testimonial Series | Daphne Technology

From exhaust gas cleaning system to easy-to-assemble face shield against COVID-19   The following article is part of BioAlps’ testimonial…

E4S

COVID-19 Testimonial Series | E4S

E4S’ Testimonial | A policy approach to fighting COVID-19   The following article is part of BioAlps’ testimonial series and…

Abionic

COVID-19 Testimonial Series | Abionic

A rapid sepsis test, the key to saving lives   The following article is part of BioAlps’ testimonial series and…

MedCo

COVID-19 Testimonial Series | MedCo

Secure, privacy-conscious data analytics among hospitals   The following article is part of BioAlps’ testimonial series and was written by…

Netsensing

COVID-19 Testimonial Series | Netsensing

Patients with sleep apnea are more at risk when infected with COVID-19   The following article is part of BioAlps’…

SIB Swiss Bioinformatics Institute

COVID-19 Testimonial Series | SIB Swiss Bioinformatics Institute

Bioinformatics, a crucial key to a rapid response to the COVID-19 threat   The following article is part of BioAlps’…

CSL Behring

COVID-19 Testimonial Series | CSL Behring

In-house expertise, strategic partnerships and collaboration   The following article is part of BioAlps’ testimonial series and was written by…

SOPHiA GENETICS and Dasa join forces to fight cancer

SOPHiA GENETICS and Dasa foster a new data-driven medicine era in the fight against cancer   On 23 July, SOPHiA…

Eye imagery

Eye imagery revolutionised

New MRI method, developed in Lausanne enhances eye imagery and clears new path for further research   Research from the…

Incyte inauguration 2020

Incyte gets installed in the canton of Vaud

Incyte inaugurates its new European HQ in Morges   In July 2020, the global pharmaceutical company, Incyte inaugurated its new…

Medtech

Artiria Medical raise CHF 3 million in series A

Artiria Medical raises CHF 3 million to improve stroke treatment   EPFL spin-off, Artiria Medical, is developing micro-actuated catheters and…

iOnctura

iOnctura raise €20 million for series A

iOnctura raise an additional €5.1 million for their series A funding, reaching a total of €20.1 million   The Geneva-based…

EMBION

EMBION™ Technologies develops a new solution

EMBION™ Technologies S.A., hard-tech, disruptive innovator in plant-based bioactives for the nutrition of the future, announces the market launch of PREMBION™. It is the first patented product with complex prebiotic properties for animal nutrition that was created with EMBION’s novel platform technology. The spin-off of the Swiss Federal Institute of Technology in Lausanne (EPFL) accelerates nutrition innovation toward increased functionality and greater affordability. It reduces the time from discovery to commercial production by up to 80%. Market introduction tests are currently underway with leading global corporations in the food, feed and drinks sectors.

CoreMedica Europe

CoreMedica Europe | Enters the COVID-19 blood test race

CoreMedica Europe | A blood test to screen your immune system   The Geneva-based startup has entered the COVID-19 diagnostics…

Polares Medical

Polares Medical raises $40M

Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies   On 25 June 2020, Polares Medical SA, a…

University of Bern

University of Bern Institute of Infectious Diseases (IFIK) opens a new laboratory

Unique biosafety laboratory at the University of Bern   On 16 June, the new BSL-3 biosafety laboratory of the University…

CoreMedica Laboratories

CoreMedica Laboratories Inc. implements Roche Elecsys antibody test for COVID-19

CoreMedica Laboratories Inc. provides COVID-19 serology confirmations via a secondary antibody detection method   On 12 June 2020, CoreMedica Laboratories,…

HMCare

HMCare to develop a transparent surgical mask

HMCare will launch the production of its HelloMask as of early 2021   For the past two years, the EPFL…

GliaPharm

GliaPharm raises CHF 1.5 million

GliaPharm reaches a total of CHF 2 million raised to further its drug development   On 25 May 2020, EPFL…

Bachem

Bachem supports the fight against COVID-19 worldwide

Bachem supplies key anaesthetic drug to support fight against COVID-19   The Swiss-based company, Bachem, is the world leader in…

BioAlps Networking Day 2020

Save the Date | BioAlps Networking Day

BioAlps Networking Day 2020 | Annual gathering of Western Switzerland’s Life Sciences’ Community   The event is planned to take…

Abionic

COVID-19 | Abionic’s solution, a life saver

Abionic’s sepsis test supports the fight against COVID-19   When the pandemic hit, Abionic was finalising a financing round to…

Lonza

Lonza & Moderna partner to produce COVID-19 vaccine

Lonza | A key player in the COVID-19 vaccine production   Lonza, the Valais-based company, has signed a 10 year…

SILAB

Partnership offer for SNF NRP78 “Covid-19” call

SNF NRP78 « Covid-19 » Call | Collaboration opportunity with SILAB   SILAB can be a real asset to develop…

ADC Therapeutics

ADC Therapeutics goes public

ADC Therapeutics chooses the New York Stock Exchange   On 15 May 2020, the Biopôle-based company, ADC Therapeutics went public….

AquaNetto | Extended use of the same mask

AquaNetto enables you to wear the same mask for an extended period of time   Based in the canton of…

COVID-19

Incyte & Novartis enter phase II trials with Jakafi drug

Partners are taking Jakafi drug into a second late-stage trial for COVID-19 patients on ventilators   On 5 May 2020,…

COVID-19

COVID-19 | AIDES POUR LES START-UP

In light of the COVID-19 situation, we are exceptionally posting information in French on our website. Do not hesitate to…

HUG Clinical Trial

COVID-19 | HUG launch a clinical trial

HUG | Preventive treatment for people in contact with COVID-19 patients   The HUG launch a clinical trial called CoPEP…

Medtronic

Medtronic shares ventilator specifications

Medtronic is publicly sharing design specifications for its ventilators to support the fight against COVID-19   Medtronic is sharing the…

COVID-19

A simultaneous diagnostic test for COVID-19, flu and SRAS infections

Adamant Innotech and CSEM develop a simultaneous diagnostic test for past COVID-19, flu and SRAS infections   On 9 April…

Quotient Limited

Quotient Limited | SARS-CoV-2 Antibody Test

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development   Vaud-based Quotient Limited announced on 6 April 20202,…

Augurix GaDia

Augurix and GaDia develop a rapid COVID-19 serological test

First rapid COVID-19 serological test to enter Swiss market   On 6 April 2020, Augurix SA and GaDia announce the…

Gnubiotics

Gnubiotics joins the fight against COVID-19

Gnubiotics accelerates testing of multivalent-glycan based pipeline candidates against viral entry of COVID-19   Since 2016, Gnubiotics has invested in…

COVID-19

COVID-19 | MESURES ECONOMIQUES

In light of the COVID-19 situation, we are exceptionally posting the information in French on our website. Do not hesitate…

Aktiia

Aktiia raises CHF 6 million

Aktiia raises new funds to finalise last steps towards market entry   Neuchâtel-based Aktiia, created in 2018, has developed a…

Medtech

New EU Medical Devices Regulation to be delayed by a year

European Commission seeks to delay the new EU Medical Devices Regulation (MDR)   Stella Kyriakides, the European Commissioner for Health…

Swiss Medtech

Information from Swiss Medtech

Swiss Medtech companies defined as part of Switzerland’s critical infrastructure   The Federal Department of Defence, Civil Protection and Sport…

Rheon Medical

Rheon Medical acquires the CE Marking

Rheon Medical to launch its eyeWatch product on the Swiss and EU markets   The Vaud-based startup, Rheon Medical, specialised…

1Drop

1Drop Diagnostics to board the International Space Station

1Drop brings medical diagnostics to space   The Neuchâtel-based company, 1Drop Diagnostics, which specialises in the detection of cardiovascular biomarkers…

Neuro

UNIFR & SICHH | New Alzheimer’s diagnosis

Teams from UNIFR & SICHH discover a new Alzheimer diagnosis solution based on saliva analysis   The University of Fribourg…

Abionic

Abionic’s sepsis test | A diagnosis solution for the new Coronavirus

Abionic’s R&D focuses on the development of an early sepsis diagnosis solution | A tool for Coronavirus identification   Abionic,…

EBAMed joins the Mayo Clinic Business Accelerator

EBAMed joins the Mayo Clinic Business Accelerator and starts pre-clinical testing   EBAMed SA, a medical technology company enabling access…

Cordsavings

Cordsavings | A Decisive Alliance in Stem Cell Biobanking

Los Angeles – Geneva – Monthey: CSG-BIO SA (CSG-Bio), which intends to offer the most advanced and comprehensive stem cell banking services to families worldwide in the near future, took over some of CryoSave AG’s assets in 2019. It has now announced the signing of an agreement with CORDSAVINGS SA (CordSavings), the reputed independent Swiss neonatal stem cells laboratory, to secure the hundreds of thousands of stem cell samples left in insecurity following the bankruptcy of the Swiss company Cryo-Save AG in September 2019.

SOPHiA GENETICS

SOPHiA GENETICS Appoints Chief Medical Officer

New appointment at SOPHiA GENETICS to accelerate the execution of its Medical Strategy   On 13 February 2020, SOPHiA GENETICS, leader…

Lunaphore

Lunaphore raises CHF 23 million

Lunaphore closes its Series C funding   On 6 February 2020, the EPFL spin-off, Lunaphore, founded in 2014, announced the…

New GE Healthcare manufacturing site in western Switzerland

New centre of excellence in the canton of Vaud | GE Healthcare Life Sciences   GE Healthcare Life Sciences will…

CSEM

ORGANTRANS | A milestone in regenerative medicine

Creation of a European Consortium | ORGANTRANS   On 4 February 2020, the CSEM announced the creation of  the European project ORGANTRANS….

Swiss Venture Capital Report 2020

Swiss Venture Capital Report 2020

The Swiss Venture Capital Report 2020 is out | Encouraging results for biotech and healthcare IT sectors   The 8th…

Novostia

Novostia receives grant from the European Commission

European Innovation Council (EIC) Accelerator | Novostia part of the 9 selected Swiss startups   The European Commission selected 75 startups…

GeNeuro

GeNeuro closes €17.5 million private placement

GeNeuro secures investment to further clinical trials   GeNeuro, the Geneva-based biopharmaceutical company, announced on 31 January 2020 the securing…

Endotelix Diagnostics

Endotelix Diagnostics wins VentureKick Stage 3

Endotelix Diagnostics Sàrl | Solution provider for Antiphospholipid Syndrome   In 2020, VentureKick allocated CHF 5 million to 80 Swiss startup projects.  …

Merck

Merck invests €250 million in Switzerland

Merck Biotech Development Center | New Facility in Switzerland   On 27 January 2020, Merck announced a €250 million investment…

Nanolive

Nanolive is moving to a new office location

Another milestone for Nanolive, as the company moves to new offices   In 2013, Nanolive started its adventure in a…

Abionic

Abionic | Hitting the European and US markets

Abionic to commercialise its rapid sepsis diagnosis product on the EU and US markets   The Abionic team, who has…

SILAB

NTN Innovation Booster | Contribute to the Future of Healthcare with SILAB

Join SILAB and take part in Innosuisse’s NTN Innovation Booster programme Imagine and develop the healthcare of tomorrow   Innovation…

qmt

Qualimatest & SAPHIR join forces to become qmt

qmt | The industry’s quality test and control reference   On 9 January 2020, SAPHIR and Qualimatest announced that their…

Healthcare Konnect

Oxipit partners with HealthCare Konnect | Press Release

Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria. The partnership aims to introduce vanguard AI diagnostic capabilities and improve detection of 75 pathologies, including tuberculosis, to one of the largest markets in Africa.

IDT partners with SOPHiA GENETICS

IDT partners with SOPHiA GENETICS | Press Release

Leading genomics solutions, combined with advanced analytics, provide benefits to hospitals and patients

BioAlps Networking Day 2019

BioAlps Networking Day 2019 Interviews

BioAlps Networking Day 2019 | Discover key speaker interviews by GGBa   The Greater Geneva Bern area (GGBa) collaborated with BioAlps once…

Neuro

NeuroRestore Center is launched

NeuroRestore Center | A new partnership to restore neurological functions through research, innovation and treatment   Defitech Foundation is partnering with…

Brain-Computer Interface

Brain-Computer Interface Technologies by Claude Clément

Brain-Computer Interface Technologies | Accelerating Neuro-Technology for Human Benefit The BioAlps team is proud to present our President’s new book….

Smart Protein

HES-SO Valais | Smart Protein Project

Smart Protein Project | In search of a meat substitute   HES-SO Valais was selected to take part in the Smart…

Positive Coating

POSITIVE COATING – 15 positive years

Fondée en 2004, POSITIVE COATING se distingue par le développement de solutions innovantes dans le domaine des traitements de surfaces basés sur les technologies PVD (Physical Vapor Deposition) et ALD (Atomic Layer Deposition), des traitements physiques et chimiques de pointe. A l’occasion de son 15-ème anniversaire, elle revient sur les grandes étapes de son parcours et donne la parole à sa direction afin qu’elle nous explique l’origine de son nom et les valeurs de l’entreprise qui ont été moteur de son succès.

microcity

Swiss serial entrepreneur joins Microcity Startup Program

Marc Thurner, founder of regenHU, Vivos Dental and mimix biotherapeutics joins Microcity as Stratup Program Manager   In October 2019,…

Entreprise Romande

Entreprise Romande – The rise of Life Sciences

The rise of Life Sciences in the past 20 years by Entreprise Romande Everything you need to know   Discover…

Agefi

Agefi – Journey to the future of healthcare professions

How will the future of healthcare professions be affected by new technologies?   Agefi’s article provides insider knowledge regarding the…

GTX Medical

GTX Medical enters the US market

“The EPFL spin-off GTX Medical moves into the US market”   The Health Valley based startup, GTX Medical, which developed…

SOPHiA GENETICS Expands it’s Executive Team

A new Chief Marketing Officer and a new Chief Information Officer have joined SOPHiA GENETICS’ Executive Team SOPHiA GENETICS, leader in…

EPFL

EPFL : The path of breast-to-brain cancer metastasis

EPFL scientists have discovered the path used by breast cancer cells to metastasize to the brain   One of the…

Fresenius Kabi

Fresenius Kabi expands biosimilar research activities in Eysins

Fresenius Kabi expands biosimilar research activities – Inauguration of state-of-the-art R&D center in Eysins, Switzerland   On 18 September 2019,…

Virdis Group

Virdis Group furthers Swiss expansion

Virdis Group announces new office opening in Lausanne, Switzerland to further Swiss expansion.

Healthcare Konnect

CureMetrix and HealthCare Konnect join forces

LA JOLLA, California, (Aug 29, 2019) – CureMetrix® a healthcare technology company that develops computer-aided detection (CAD) artificial intelligence (AI) based radiology software, announced that it entered into an agreement with HealthCare Konnect, to bring CureMetrix AI technologies to healthcare institutions in Nigeria and Algeria. The organizations will collaborate to support the clinical advancement of AI technologies to improve breast cancer detection in these regions.

University of Fribourg

Fribourg University Launches A New Master of Medicine

A new Master of Medicine was launched this autumn at Fribourg University, designed in collaboration with the Fribourg Hospital (HFR)…

Abionic

Efficiency Proof of Abionic’s Revolutionizing Sepsis Diagnosis Solution

International pivotal study successfully demonstrates Abionic’s diagnosis of sepsis within 5 minutes – 24 hours earlier compared with current standard-of-care…

EPFL

At EPFL AI fosters synergy between man and robot

EPFL scientists are using AI to improve control over robotic hand use for amputees   Artificial Intelligence (AI) is used…

HUG

Artificial Intelligence supporting HUG’s cancer treatment solutions

This year, HUG have implemented Watson for Genomics: the search engine based on tumour genetic information   Watson for Genomics…

Abionic

Abionic Signs Agreement with Genentech

Abionic and Genentech have signed an agreement to develop and provide rapid Point-of-Care tests for Asthma in the US  …

Swiss-based startup EBAMed raises CHF 1.2 Million

Funding supports development of first integrated heart motion management
system and pre-clinical testing

Drug Delivery

A glass needle gives new hope

A minuscule needle synonymous of hope for 16 million patients   FEMTOprint has developed, in partnership with the EPFL and…

ADC Therapeutics and SOPHiA GENETICS partner for biomarker discovery

ADC Therapeutics and SOPHiA GENETICS Partner in Pivotal Phase II Clinical Trial   Study to identify genomic markers associated with…

HUG

A magical healing sponge

HUG‘s Experimental Cell Therapy Lab has developed a stem cell based magical healing sponge   The bioabsorbable sponge has proven…

CHUV

Professor Solange Peters & team receive the Bonnie J. Addario 2019 prize

CHUV Professor Solange Peters & team were granted this year’s GO2 Foundation prize   This year’s Bonnie J. Addario prize…

Smart Protein

Pharma industry is boosting Swiss exports

Pharma products take first place on the Swiss export board   The high demande from international markets drives Swiss pharma…

Pryv and BGO launch privacy-centric eCRF solution

The innovative RWD eConsent solution is ideal for enhancing clinical trials with Real-World Data (RWD), achieving privacy compliance and improving patients’ engagement.

Switzerland, Morges, 12 June 2019 – Pryv, the leading Swiss provider of privacy and personal data management software, and BGO Software, a Bulgaria-based leading software services and product development company, have announced the launch of an innovative eCRF solution to manage Real-World Data (RWD) and informed electronic consent (eConsent).

UNIGE HUG

New head of UNIGE’s Faculty of Medicine and HUG’s Teaching and Research Department

Professor Cem Gabay has been appointed as the new Dean of the Faculty of Medicine (UNIGE) and Head of the…

AMAL Therapeutics acquired by Boehringer Ingelheim

Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform   Boehringer Ingelheim announced…

CSEM

A “smart bra” for detecting breast cancer

Introducing the SBRA “smart bra” project   The SBra project aims to develop an intelligent bra, equipped with sensors, capable…

Sophia Genetics

SOPHiA GENETICS welcomes Troy Cox to its Board of Directors

Troy Cox joins SOPHiA GENETICS as the company expands its decentralized approach to Data-Driven Medicine to foster a sustainable and…

UNIGE – Medicines made of solid gold

Medicines made of solid gold to help the immune system   By studying the effects of gold nanoparticles on the…

UNIGE

UNIGE – Detecting problems of the anti-bleeding system in 60 minutes

UNIGE and Franche-Comté University researchers have co-developped an innovative device enabling platelet capacity detection   This tool investigates a patient’s…

UNIGE

UNIGE : Yves Flückiger appointed as Rector for a second term

The appointment of the new rectorate of UNIGE by the Council of State was revealed on Thursday 20 June 2019.   Prof….

The Wyss Center has a new Director

Dr Mary Tolikas has been appointed as the new Director of the Wyss Center   “The Executive Board of the…

UNIGE and UNIL : “A model to decipher the complexity of gene regulation”

Scientist at the Universities of Geneva and Lausanne, Switzerland, designed a framework to analyse gene regulation, and offer a model…

Asceneuron : New member appointed to the Board of Directors

Asceneuron, an emerging leader in the development of orally bioavailable modulators of tau for the treatment of neurodegenerative diseases, today announces the appointment of Dr Eric Yuen to its Board of Directors.

The 2019 Global Startup Ecosystem Report is now available!

The Bern-Lausanne-Geneva region has been ranked #22 worldwide in this year’s edition of the Global Startup Ecosystem Report   Not only…

SICHH

The Swiss Integrative Center for Human Health (SICHH) and the Human Brain Project (HBP) unite

The SICHH and the HBP unite to further research on Alzheimer’s disease and dementia.   The SICHH welcomes the HBP…

Deep Cube – A Success Story

Watch Deep Cube‘s video and learn more about one the canton of Vaud’s striving startups!        

Back to the sources of neural diversity

By deciphering the genetic programmes of neurons of the cerebral cortex, Swiss and Belgian researchers unravel the mechanisms controlling the…

Avatarion will be present at the Digital Heath Connect

Avatarion : Robots in healthcare   The Digital Health Connect will take place on 7 June in Sierre in the…

EPFL Innovation Park

The startup as an innovative partner

Creating bridges between a large corporation and start-ups is not always an easy task. However, this becomes indispensable to ensure its capacity for innovation. For example, if one is an insurer, seeking to enhance the value of billions of medical data to help your clients stay healthy, developing partnerships with start-ups specializing in artificial intelligence is necessary. It is no longer possible to do everything internally. So how to make these bridges less slippery?

A natural barrier which prevents tumors from metastasizing

EPFL scientists have discovered a natural barrier which prevents tumors from forming new tumors or metastasizing.    Scientists from the…

SamanTree Medical

SamanTree Medical raises CHF 9.5 million

SamanTree to start commercializing its Histolog Scanner The Lausanne based startup has raised CHF 9.5 million to help launch the…

BioAlps Networking Day

Save the Date : BioAlps Networking Day 2019

The event will take place on 29 October 2019 @ Théâtre du Crochetan, Monthey (VS).   Our afternoon event will…

MindMaze

MindMaze – “Gamifying rehabilitation for stroke survivors”

Tej Tadi, founder of MindMaze, redefines stroke treatment via virtual reality   The Guardian highlights MindMaze‘s advancement in the field of…

Volumina Medical

Volumina Medical rewarded at the Startup Champions Seed Night

Volumina Medical won the Seed Night prize for its injectable implant.   The event organized by the EPFL, Venturelab and…

Sophia Genetics

A new achievement for SOPHiA GENETICS

SOPHiA GENETICS’ Solid Tumor Solution (STS) receives the CE-IVD marking   Western Switzerland based global leader in Data-Driven Medicine, SOPHiA…

EspeRare

EspeRare announces a partnership with Dermelix Biotherapeutics

EspeRare annonce un partenariat avec Dermelix Biotherapeutics pour DMX-101, et le lancement de la phase pivotale pour une thérapie in utero pour XLHED

ERC

EPFL professors awarded ERC Advanced Grants

Two EPFL professors received ERC Advanced Grants for their research in cell science and immunotherapy   Professors Pierre Gönczy and…

The Swiss Venture Capital paradigm is shifting

Is Swiss Venture Capital now rising too fast?   A few years back, Swiss pension funds remained cautious when it…

EPFL

EPFL : A new achievement towards personalized medicine

Scientists from EPFL’s BionanoPhotonic Systems (BIOS) Laboratory have created a powerful sensor which will be able to support at-home disease identification.  …

CHUV

CHUV : Prof Pantaleo’s HIV discovery recognized world wide

Prof Pantaleo’s work published as part of the “Milestones” edition of Nature.   In this edition, Nature identifies the 21…

Tech Tour Award

SOPHiA GENETICS wins the 2019 Tech Tour Growth Award

SOPHiA GENETICS was awarded the 2019 Tech Tour Growth Award out of a pool of 50 companies.   The selecting…

EPFL’S Blue Brain Project breakthrough

The EPFL’s Blue Brain Project has identified how to mathematically determine a neuron type classification based on the neuron’s shape….

An established antibiotic could help treat an aggressive form of breast cancer

UNIGE and UNIL scientists have discovered that clofazimine can be used to reduce tumors in the case of “triple negative” breast…

“Engineering cellular function without living cells”

Imitating the complexity of cellular function while having access to a simpler system which can be mathematically altered.   Scientists…

Aktiia

Aktiia changes the cuffless blood pressure measurement paradigm

Aktiia’s cuffless blood pressure measurement device only needs calibrating every two months   Aktiia’s founders have worked for the past…

Digital Health Hub

Launch of the Digital Health Hub @Biopôle

On 14 March 2019, the Digital Health Hub was launched @Biopôle   The Digital Health Hub was inaugurated today @Biopôle…

Blood Cells

Vitamin B3 analogue increases the efficiency of certain cancer treatments

Intake of Vitamin B3 analogue increases blood cell creation and in-turn positively impacts leukemia and aggressive lymphomas treatments.   Scientists…

MedCo : Medical data safely accessible

The MedCo software, developed by EPFL and CHUV researchers, grants access to medical data from different sources while respecting the…

Using Bioinformatics to Understand Genetic Diseases

The Swiss Bioinformatics Institute (SBI) and the University of Manchester have published a Practical Guide to understand “basic bioinformatics approaches…

Novostia

Neuchatel based Novostia raises CHFF 6.5 million

The funds, raised from private investors, will support Novostia in carrying out the first clinical trials.   Novostia has developed, in…

Innovaud

Scale Up Vaud: 2360 jobs worldwide in 2019

“The Scale Up Vaud initiative continues to grow and welcomes five new members.”   Innovaud shares the outcomes and statistics…

SimplicityBio

Precision for Medicine acquires SimplicityBio

The Valais based startup, SimplicityBio acquired by the USA group Precision for Medicine on 6 March 2019.   Precision for…

EPFL – The bacteria’s gait

“Bacteria walk (a bit) like we do”   Research at the EPFL’s Institute of BioEngineering and Global Health has been…

HUG

HUG breakthrough – Towards a personalized vaccine against brain cancer

The HUG, as part of the GAPVAC (Glioma Actively Personalized Vaccine Consortium) consortium financed by the European Union, have reached a…

Nanolive

Nanolive : T-cells killing cancer cells

Nanolive SA develops a high speed, high resolution and label-free live cell imaging microscope to look instantly inside living cells in…

Lunaphore

Lunaphore’s first product reaches the market

EPFL spin-off, Lunaphore released on 7 February 2019 it’s “rapid screening test for cancer”.   Lunaphore has acquired the CE…

CSEM

CSEM News : First successful osseo-neuromuscular implant

CSEM has contributed to the first dexterous and sentient hand prosthesis implant.   A female Swedish patient with hand amputation has…

Launch of the Swiss stress network

Over 30 scientists from different Swiss universities have joined the newly launched Swiss stress network.   The network enables thorough…

Lonza

Lonza to invest CHF 1 billion over 3 years in its Swiss sites

“Lonza invests 12% of its sales revenue in its plants” in Visp (VS).   Marc Funk will replace Richard Ridinger…

ChemAlive moves to the business stage

Congratulations to ChemAlive, the Lausanne (Vaud) based startup, who has just moved from its R&D to its business phase! “… The…

Alzheimer

Progressive signaling changes in the olfactory nerve of Alzheimer’s disease patients

SICHH contribue à une avancée dans la recherche des symptômes précoces de la maladie d’Alzheimer. L’équipe du Dr Alberi publie un manuscrit scientifique qui démontre pour la première fois que le nerf olfactif subit des altérations morphologiques précoces au développement de la démence.

ADC Therapeutics

ADC Therapeutics launches Phase I clinical trial

The Swiss based startup, ADC Therapeutics, has dosed a solid tumor patient in its first Phase I clinical trial.  …

EPFL and UNIL discovery : How a mutated gene can lead to different forms of cancer

“EPFL and UNIL scientists have discovered how a mutated gene can affect the three-dimensional interactions of genes in the cell,…

EPFL and ETH scientists have developed smart microrobots

Research from EPFL and ETH Zurich has lead to the development of microrobots capable of changing shape to according to…

Sophia Genetics

Sophia Genetics signs over 850 hospitals to its “data-driven medicine”

Sophia Genetics closes it Series E funding round with a $77 million cash injection. The Swiss biotech is now used…

MindMaze

MindMaze has become the first Swiss unicorn

MindMaze, spin-off of the EPFL, has developed a neurological rehabilitation system called MindMotionPRO. This system supports patients in their recovery from a…

GSK President announces his departure

GlaxoSmithKline‘s President, Philip Hampton,  has announced his departure a month after the British pharmaceutical group unveiled its plan to create…

11 EPFL Startups @ CES19 in Las Vegas

Eleven startups from EPFL were present @ CES19 this January. The event was a chance for them to showcase their…

Chemotherapy-treated tumors fight back

Researchers at EPFL have discovered that chemotherapy-treated mammary tumors create small vesicles that help them reach new organs. Read the…

Bristol-Myers Squibb to Acquire Celgene for About Billion

“The combined company will have nine products with more than billion in annual sales” Read full article in English from…

EPFL startups raised CHF 217 million in 2018

What a year for EPFL startups with a total amount raised of CHF 217 million in 2018! The investment was…

GSK and Pfizer to create a joint venture

GSK and Pfizer are joining forces to become a worldwide non-prescription drug giant.   Read AGEFI’s full article in French

“X chromosome: how genetics becomes egalitarian”

UNIGE researchers have observed how the second X chromosome in women is gradually inactivated cell by cell to avoid identical…

UNIGE

UNIGE researchers develop U-ExM: expansion microscopy

The University of Geneva researchers have developed U-ExM which delicately inflate cells to facilitate an efficient imaging of cellular ultrastructures….

HES-SO launch two personalized medicine national projects

The projects link personalized medicine and AI to offer the most efficient support at different stages of illness. Read full…

Meet Christophe Ramstein, CEO of Myotest

The Valais based startup provides personalized smart coaching software and services for runners to achieve their performance goals confidently, improve…

Using water molecules to unlock neurons’ secrets

EPFL News : “EPFL researchers have developed a method to observe the electrical activity of neurons by analyzing the behavior…

Grifols

Protéine anti-interférence pour la sécurité des transfusions sanguines chez les patients cancéreux

Medion Grifols Diagnostics finaliste du Prix Entreprise 2018/2019 du Canton de Fribourg. “Des nouveaux médicaments contre le cancer affectent les…

Industrialisé avec le soutien technologique du CSEM, SUN bioscience lance sa plateforme Gri3DTM.

Cet outil représente une première et propulse les organoïdes dans une nouvelle La culture in vitro standardisée, rapide et fiable…

Médecins, mais entrepreneurs dans l’âme

“Deux médecins, l’un au CHUV et l’autre aux HUG, développent des applications qui pourraient s’avérer révolutionnaires. Celles-ci transforment les smartphones…

BioAlps Prize 2018

We are very proud to announce the winners of the BioAlps Academy and Industry Prizes 2018. The BioAlps Award aims…

ADC Therapeutics: pemiers patients traités en Phase I/II sur ADC -602 pour le traitement de leucémie

ADC Therapeutics annonce les premiers patients traités dans le cadre de l’essai clinique de Phase I/II sur ADCT-602 dans le…

Blue Brain Project releases first-ever digital 3D brain cell atlas

“Like “going from hand-drawn maps to Google Earth,” the Blue Brain Cell Atlas allows anyone to visualize every region in…

“More than gut feeling”: Microbiota modulation technology scores at HiE 2018

“GNUBiotics (Switzerland) has won the Ingredients category in the Startup Innovation Challenge at HiE 2018 in Frankfurt. The company is…

Genève inaugure un centre de lutte contre le cancer

Le Centre de recherche translationnelle en onco-hématologie (CRTOH) a été inauguré lundi 26 novembre 2018 à Genève. Cette structure, réunissant…

EPFL partners with Standford to advance life science research

“Catalyze4Life, an Innovation Initiative of EPFL has partnered with the similar SPARK program at Stanford University to further advance its…

Caroline Heid à la tête de Microcity

Neode devenu Microcity, nomme Caroline Heid comme Présidente Lire l’interview de la nouvelle présidente

A hydrogel that adheres firmly to cartilage and meniscus

“EPFL researchers have developed a hydrogel – made up of nearly 90% water – that naturally adheres to soft tissue…

UNIGE: “Le tamoxifène peut freiner la myopathie myotubulaire”

“Des chercheurs de l’Université de Genève (UNIGE) ont identifié une molécule appelée tamoxifène, qui peut arrêter la progression de la…

Science is keeping pace with marathoners

“Thanks to sensors attached to their shoes, long-distance runners can harness the power of algorithms to analyze their stride. The…

Immunity connects gut bacteria and aging

“EPFL scientists have discovered how a dysfunction in the immune system can cause an overload of a gut bacterium. The…

AMAL Therapeutics raises 33.2 million dollars

The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2 million. Read Venturelab‘s…

World Visibility Package 2022

BioAlps World Visibitlity Package 2019

A yearly international programme for our affiliated companies to increase their visibility. “BioAlps Bridging the World” are events giving you…

SEED Biosciences joins three talented ventures at StartLab

“Personalized medicine enabler SEED Biosciences will be the 4th start-up to join Biopôle’s StartLab, the first incubator dedicated to life…

Hidden estrogen receptors in the breast epithelium

“EPFL scientists have uncovered that next to estrogen receptor-positive and -negative cells, there are cells with very low amounts of…

Neode SA devient Microcity SA

“​Afin de soutenir la création et le développement d’entreprises innovantes et de fournir des prestations facilitant le transfert de technologie…

Chemiextra ILMAC 2018

Zusammenfassung der Veranstaltung Den ganzen Artikel lesen

1DROP Diagnostics raises 4.25 million dollars

“Investment will support commercialization and development of panels of new diagnostic tests” Read full article

Chercheuse récompensée à l’Uni de Berne

“L’Université de Berne a distingué la médecin Stephanie Ganal-Vonarburg pour ses travaux sur l’influence des microbes intestinaux de la mère…

TWIICE One exoskeleton is a step towards independence

“The new version of the TWIICE walking-assistance system is not only lighter, more comfortable and more powerful, but patients can…

Innosuisse recrute

Innosuisse recherche un/une collaborateur/collaboratrice scientifique (80-100%) pour l’équipe TST Ce poste s’insère dans la tâche passionnante d’aider à mettre en…

Andrea Ablasser wins the 2018 National Latsis Prize

The medical researcher and EPFL professor Andrea Ablasser, who studies how cells defend themselves against viral and bacterial attacks, has…

Biopôle continues expansion with new building construction

Biopôle has signed a partnership agreement with EPIC Suisse for the construction of a new building @ Epalinges. Construction of…

Breakthrough neurotechnology for treating paralysis

Three patients with chronic paraplegia were able to walk over ground thanks to precise electrical stimulation of their spinal cords…

2018 Technology by Bilan

The latest edition of Technology by Bilan magazine is out today! Great articles and insights from our HeatlhValley key players.

Andhra Pradesh MedTech Zone Limited (AMTZ)

AMTZ-The MedTech Capital of India AMTZ is creating an ecosystem for promoting medical device manufacturers, innovators and startups at Visakhapatnam,…

Innosuisse lance son programme d’impulsion “Technologies de fabrication”

Ce programme d’impulsion s’adresse à des consortiums d’entreprises et de laboratoires désireux de développer des projets d’innovation dans les domaines…

EPFL News – The “nerve-on-a-chip”

“EPFL scientists have developed a miniaturized electronic platform for the stimulation and recording of peripheral nerve fibers on a chip.”…

Switzerland Global Enterprise – Technologies Médicales. La Suisse, Terre d’Opportunités

Lire l’article complet sur le site de la Switzerland Global Enterprise. Dans le cadre de la collaboration Franco-Suisse, un déjeuner d’affaires est organisé à…

AGEFI – Endeavour Vision parmi les leaders mondiaux

Le VC genevois se spécialise dans les medtech Lire l’article complet de l’AGEFI paru le 31 août 2018.

Cendres + Métaux affiche une croissance de 8%

La société biennoise, qui à l’origine se spécialise dans le traitement des métaux précieux, augmente sa croissance grâce à la…

Fribourg – Des soutiens financiers accrus en faveur des PME désormais disponibles

Le 1er octobre, la loi révisée sur la promotion économique entre en vigueur, ainsi que son nouveau règlement adopté par…

Le Valais, Pionnier des biotechnologies ?

Lisez le blog de The Ark Foundation et visionner l’émission Eco-Logique de Canal 9 qui met en avant l’exemple du…

Addex renoue avec les bénéfices au 1er semestre

Addex est retourné au premier semestre en territoire positif au niveau du résultat net, inscrivant un bénéfice net de 2,4…

Obseva: résultats prometteurs pour le traitement linzagolix

Final results of ObsEva SA Phase 2b EDELWEISS trial of Linzagolix show sustained efficacy and Bone Mineral Density safety, for…

Alcon arrive à Genève

Alcon quitte Novartis et choisi le canton de Genève pour s’installer avec une équipe de 700 personnes. Article complet en français…

Biotech, Medtech et Pharma, un trio performant

Plusieurs acteurs de la Health Valley analyse les forces de la région de La Côte dans le domaines des sciences…

Lonza investit 400 millions de CHF à Viège (VS)

Lonza poursuit son développement en finançant la création de deux nouveaux sites dans le Canton du Valais. Article complet en français…

Addex Pharma – recoit un financement de 1,2 M£

Addex ADX10061 Receives £1.2 million Funding for Manufacture and Investigator Led Clinical Studies as part of the Tools for Human…

La convergence des technologies: Contributions aux laboratoires du futur

Article BioAlps paru dans le Magazine Chemiextra de septembre 2018, dans le cadre de l’ILMAC Lausanne.  

Alcon, the eye unit of Novartis will move its headquarters to Geneva after spin-off

On 11 September 2018, Alcon announced that it will move its headquarters to Geneva after spin-off from Novartis. Read full…

La thérapie génique d’Haya contre les maladies cardiaques

Deux fois par semaine Bilan propose le portrait d’une start-up suisse pour investir issues de sa sélection 2018. Aujourd’hui, Haya…

Celgene renforce sa présence à Neuchâtel

Le groupe pharmaceutique américain a inauguré mardi une nouvelle usine à Couvet avec 100 emplois à la clé. Article publié…

Cybermedicine

Cybermedicine : Our society must make choices

What is Cybermedicine’s place in today’s society?   Professor Antoine Geissbuhler, Medical-Head of the Department of CyberHealth and Telemedicine and…

Mapping the brain

Computer science teams up with neuroscience in frontier EU research Read the full article about this colossal project

Our immune responses differ due to age, sex and genetics

Age, sex, and specific human genetic variants are the key factors behind differences between immune responses among healthy humans, finds…

Gene Predictis SA et Synlab Suisse SA annoncent un partenariat stratégique

En vue, la commercialisation conjointe d’un test génétique novateur permettant de mesurer le risque de thrombose associé à l’utilisation de…

Pioneering work from HUG and UNIGE for a safe EBOLA virus vaccine

An Ebola signature The team has successfully defined a “formula” capable of predicting the efficacy and safety of new Ebola…

Un « cocktail » permet aux fibres nerveuses sectionnées de repousser

Des scientifiques ont élaboré une recette en trois étapes qui permet de régénérer chez le rongeur des fibres nerveuses médullaires…

Connaissez-vous vos microbiotes?

Dans un contexte de recherche scientifique mondiale jugée exponentielle, les experts des Hôpitaux universitaires de Genève (HUG) et de l’Université…

“C’est la révolution que l’on attendait contre le cancer”

Lisez l’article de Fabrice Delaye publié dans Bilan Magazine “Alors que le CHUV inaugurera bientôt un centre de recherche dédié, le professeur…

Joint the CES 2019 Las Vegas – January 8-11, 2019 – Swiss Pavilion

Information and Registration CES 2019  January 8-11, 2019

Joint the “Data & Electronics Business Mission”, Silicon Valley / CES 2019 Januray 6-12, 2019

Information and Registration on Data & Electronics Business Mission USA January 6-12, 2019

Apidel SA annonce une levée de fonds auprès d’investisseurs privés

Apidel SA annonce aujourd’hui sa troisième levée importante de fonds auprès d’investisseurs privés. Celle-ci va notamment permettre à l’entreprise de…

Interview du nouveau Président de BioAlps par l’Agefi

Philippe D. Monnier a parlé avec Claude Clément, nouveau Président de BioAlps, de son nouveau rôle et sa vision pour…

InnoSuisse answers your questions

You wish to know more about the funding of innovation projects? You are interested in making a project proposal? Or…

Un traumatisme cérébral détecté en dix minutes

Une goutte de sang suffit à un boîtier mis au point par des chercheurs genevois et espagnols pour diagnostiquer rapidement…

GENOME JUMPER

Un jeu mobile pour explorer la diversité humaine. Comment se fait-il que certaines personnes n’aient pas d’empreintes digitales? Ou que…

Pryv partners with Net4all to launch a managed hosting solution for privacy and personal data manage

This partnership will ensure that sensitive personal data is duly managed thru its lifecycle and kept completely secure under the…

Agefi – Nouvelle présidence chez BiopAlps

Claude Clément reprend la présidence de BioAlps, l’association des sciences de la vie de Suisse occidentale. Lien à l’article de l’Agefi

IAVI, Selexis SA and Collabotators publish a new study

Paper in Frontiers in Immunology Describes Trimer Design and Development of Production CHO Cell Lines That Generate Properly Folded HIV-1…

Recherche de partenariat – Détection Cancer du sein

Recherche d’une entreprise pour un projet dans la détection du cancer du sein Dans le cadre du projet franco-suisse “SBra”…

Kinntek chooses Pryv

Kinntek, announces that it has chosen Pryv to extend its breakthrough hand rehabilitation interactive platform with advanced privacy-preserving capacity. Read…

Oculis raises CHF20 million and moves to Switzerland

Oculis, a clinical-stage biotechnology company focused on the development of non-invasive topical treatment for back-of-the-eye diseases, announced it has successfully…

14ème édition du Prix à l’innovation du canton de Fribourg

Fribourg recherche les entreprises et les start-up les plus innovantes Toutes les entreprises établies dans le canton de Fribourg peuvent…

Swiss BioInformatics Institute celebrates its 20th anniversary

BIOINFORMATICS, A SWISS PRIDE – 20 YEARS OF SERVICE TO THE LIFE SCIENCES AND HEALTH As a pioneer in the…

EspeRare gains rights to relaunch late stage development for a rare genetic disease

EspeRare is delighted to announce that it has concluded an important agreement with Edimer Pharmaceuticals. Lire le communiqué de presse…

Retraites Populaires and Biopôle SA launch the first life sciences incubator in Canton of Vaud

9,100 m2 building, funded and constructed by Retraites Populaires on the site of Biopôle, a leading Swiss life science park….

BioFoundry – Open Insulin Project – Call for Partnering Proposals

The Open Insulin mouvement was started in California with the intention of bringing the price of insulin down. The project’s…

SimplicityBio – Sales Manager position now open

The Swiss based company, founded in 2015, active in the discovery of novel medical biomarkers by means of patented bioinformatics…

Anergis and Mymetics Start Research Collaboration Project

Mymetics Corporation (OTCQB:MYMX), a pioneer and leader in the research and development of virosome-based vaccines, and Anergis SA, a company…

Gene Predictis – Tests génétiques pour prévenir les risques liés aux effets adverse

Des tests pour réduire les risques d’effets nocifs liés aux médicaments et à la nutrition. Un article de l’AGEFI La…

Selexis SA hires new strategic partners to strengthen its cell line development services

Selexis SA announced on 11 April that “it has made key strategic hires, signed its one hundredth commercial license agreement (CLA)…

Ferring acquires Rebiotix Inc.

Ferring announces their acquisition of Rebiotix Inc., microbiome pioneer. “This acquisition brings together two innovative healthcare companies that share a…

ADDEX THERAPEUTICS Sucessfully Raises CHF40 million in Capital Increase

“This is a transformational event for Addex which will enable us to advance our portfolio of allosteric modulator drug candidates…

Le Biopôle recrute un/une “Marketing & Communication Manager – 80% “

La personne sélectionnée sera en charge de la stratégie et les actions marcom du Biopôle Plus d’informations

Medtronic

MEDTRONIC – Open Innovation Days

Presentation of some of the company’s most advanced manufacturing facilities at Tolochenaz on 3 May 2018 Medtronic is among the…

Genomic Health: New Real-World Clinical Practice Data

Genomic Health today announced the presentation of new data with the Oncotype DX® test at the 11th European Breast Cancer…

Discover regenHU’s 3DDiscovery Evolution bio-printer

regenHU will launch their new product @ the IDTechEX Show on 11-12 April 2018 in Berlin, Germany.   regenHU’s 3DDiscoveryTM…

Lunaphore

Lunaphore collaborates with PerkinElmer

The Swiss start-up announced on 20 March that it will collaborate with the American multinational corporation to develop staining and…

La 2ème édition d’Orthomanufacture

Fort du succès enregistré à St Etienne en juin dernier, Orthomanufacture récidive à Yverdon-les-Bains les 20 et 21 juin 2018….

Lundbeck to acquire Prexton Therapeutics

This acquisition will add foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s…

Le Challenge Debiopharm Inartis

La qualité de vie du patient en cours de traitement “Qui pourra changer le monde dans lequel nous vivons?” «Construisons…

Luc Stoppini raconte son Prix BioAlps

Prix BioAlps 2017 : la récompense d’une carrière Article du magazine HEPIA news – Mars 2018

Glenmark Pharmaceuticals S.A. to invest in new Translational Research Group @ Biopôle

Glenmark Pharmaceuticals announces it will enhance its capabilities in translational research by opening a new discovery centre at the Biopôle…

Kick-off Medtech Accelerator at EPFL Innovation Park

Monday 12 March @ 17:30, at room Neptune, Building C of EPFL Innovation Park Learn more about La Forge’s new…

Compugen Has Licensed Selexis’ Cell Line-Based Protein Expression Platform for the Development of An

Selexis SA announces that Compugen Ltd. has taken a license to the Selexis SUREtechnology Platform™ for use in generating high-performance…

Selexis SA and Xencor sign 4 Commercial License Agreements

On 26 February, Xencor Signs Four Commercial License Agreements with Selexis SA to Advance its Pipeline of XmAb Bispecific Antibody…

UNIBE – Des cultures cellulaires en 3D contre les résistances des cancers

La médecine de précision, c’est-à-dire la mise au point de traitements personnalisés, est un objectif majeur de la recherche moderne…

Business offer from a German company represented by the Enterprise Europe Network

A German company, part of the Enterprise Europe Network, specialized in planning and interior fitting of hospitals and veterinary clinics…

Ferring: 30 million CHF investment in new biotech centre in Switzerland

Ferring expands its capabilities in biologics through a new biotech centre, which will be installed at its global headquarters and…

Fondation BINC-Geneva – Appels à candidatures

Appels à candidatures pour des financements de recherche (académiques) dans les domaines du microbiote, allergie, obésité infantile et dépression postpartum….

Bilan – Les start-up suisses lèvent un milliard en 2017

600 millions de francs d’investissements en 2017 pour les start-ups Medtech et Biotech en Suisse Lire l’article complet sur la…

Quatre plateformes promeuvent l’innovation en Suisse occidentale

Le Journal Entreprise romande nous dévoile les coulisses des quatres plateformes sectorielles de Suisse occidentale L’article complet est disponible ici.

Launch of The Innovation Finder, a free platform for the innovation actors in Switzerland

The Innovation Finder’s scope is to highlight innovative companies and institutions in the region. The platform contains valuable and complete…

Comment la «Health Valley» séduit les start-ups

«Ici, il y a une vraie convergence entre les technologies informatiques et le domaine médical, créant un environnement très dynamique…

Quartz Bio becomes part of Precision Medicine Group

US-based Precision for Medicine, part of Precision Medicine Group, today announced it is expanding its biomarker data management and translational…

CSEM News

SENSOR-ENHANCED SURGICAL ROBOT ENABLES HIGHLY PRECISE AND SAFE SPINAL OPERATIONS Researchers from the University of Bern, Inselspital, Bern University Hospital…

Bilan – Les Métiers de Demain

Le magazine référence nous informe des nouvelles formations et de leur impact sur l’avenir des métiers de la santé en…

Biopôle recrute un/e Responsable de Laboratoire

Crée par le canton de Vaud (2004), Biopôle est un parc scientifique et une communauté dynamique qui regroupe campus de…

BIOPOLE appoints STARTLAB Advisory Board members & announces first company selected

Appointments made to StartLab Advisory Board 1st candidate: HaYa Therapeutics & GNUbiotics, selected for dedicated life sciences incubator Plug &…

UNRAVELLING THE SECRETS OF THE BRAIN

Bilan and BioAlps special webdoc edition How Western Switzerland’s neurosciences cluster is turning research into innovation. Within a decade, Western…

BioAlps Bridging the World : Worldwide Visibility Package 2018

A yearly international programme for our affiliated companies to increase their visibility A yearly international programme for our affiliated companies…

Incyte est sur le point d’implanter une usine de production à Y-PARC

Incyte est sur le point d’implanter une usine de production à Y-PARC et d’offrir de nouvelles opportunités d’emploi et de…

Nov 1st, OM PHARMA CÉLÈBRE 80 ANS D’EXCELLENCE

80 ANS D’EXCELLENCE BIOPHARMACEUTIQUE À GENÈVE – DE LA BACTÉRIE AU COMPRIMÉ OM Pharma Press Release OM Pharma in the…

ADC Therapeutics raises 200 Million $ Private Financing

ADC Therapeutics Announces Closing of 200 Million $ Private Financing to Fund Two Lead Programs more info

Meet the young graduates in engineering from the University of Applied Sciences

The next forum for the graduates from HES-SO will take place on March 7th, 2018 in the convention center in…

Nouvelle Application – Journal de la recherche HEIA-FR

Mesdames, Messieurs, Nous avons le plaisir de vous informer que le journal de la recherche de la HEIA-FR est désormais…

Le Réseau romand d’oncologie réunissent les compétences d’expert

Initié par le CHUV et les HUG, avec le soutien des fondations Philanthropia et Famsa,le Réseau romand d’oncologie met à…

NeoGenomics Announces the Opening of its First International Laboratory near Geneva, Switzerland

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services in the United States, announced today that it has opened…

Prix Perl 2018

Les PERL sont devenus au fil des ans un élément central du soutien de Lausanne Région aux entreprises établies sur…

Pryv SA closes 1.1M CHF Pre-Series A to accelerate growth and prepare Series A funding round

Pryv SA, an independent Swiss Health-IT company, specialized in providing innovative data management and digital privacy solutions, is proud to…

Swiss-German Cooperation Days Biotechnologies 2017

Schlieren, 27.9.2017: Symposium Biotechnologies with Networking Event On behalf of the German Federal Ministry of Economic Affairs and in cooperation…

Swiss-German Cooperation Days Biotechnologies (25.-29.9.2017)

27.9.: Symposium „Laboratory 4.0 and new solutions for efficient processes in biotechnology“ 26.-28.9.: Cooperation talks with potential partners from Germany…

new funding opportunity for ‘Young Researchers’ Exchange Programme’ between Switzerland and Korea

20 fellowships PhD students and young postdocs from Swiss and Korean Universities and Research Institutes a new funding opportunity for ‘Young…

Anergis Announces Results of the ATIBAR Trial

Anergis, a company developing proprietary ultra-fast allergy immunotherapy, announced today the top-line results from the ATIBAR trial, a Phase IIb…

Welcome To Health Valley

Building on skills honed over the centuries, western Switzerland has become a world leader in biotech.    

Vous recherchez un·e stagiaire ou collaborateur ?

Vous avez besoin d’un stagiaire pour avancer dans un projet ? Vous souhaitez recruter un·e diplômé·e ? L’Université de Lausanne…

APPLY NOW : StartLab, the brand new incubator dedicated purely to life sciences

APPLY NOW : StartLab, the brand new incubator dedicated purely to life sciences. The perfect environment for aspiring entrepreneurs to…

Biopôle announces StartLab, tailor-made Incubator for Life Sciences Entrepreneurs

Biopôle SA, a leading Swiss life sciences park, today announced the creation of StartLab, the first incubator dedicated to life…

Merck KGaA, Darmstadt, Germany Licenses Selexis SUREtechnology Platform for Immuno-Oncology Antibody

Geneva, Switzerland, 30 MAY 2017 – Selexis SA, a pioneering life sciences company and a global leader in mammalian cell…

Apidel SA announces R&D collaboration with DNDi in the field of neglected diseases

Apidel announces the signature of an agreement to collaborate with DNDi on the preclinical development of a topical treatment for…

Selexis SA and OSE Immunotherapeutics Sign Commercial License Agreement to Further Advance Developme

Selexis SA and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today the signing of a commercial license agreement that…

Séance d’information du CAS/DAS/MAS en droit de la santé

Cette soirée d’information présente la formation continue en droit de la santé de l’Université de Neuchâtel, organisée en collaboration avec…

swissnex India’s Medtech Road Show in Switzerland

Want to be part of the Indian 10 billion CHF Medtech market? Meet swissnex India’s experts from June 12th to…

Health Valley and Swiss Franc

Medtech and biotech resisting Switzerland’s strong currency The life sciences sector continues to grow – and draw in investment and…

Valtronic célèbre son 35e anniversaire

Valtronic, innovateur et fabriquant de produits électroniques miniaturisés et de haute précision pour l’industrie des dispositifs médicaux, célèbre son 35e…

Lonza et Sanofi investissent 290 millions en Valais et créent 200 emplois

Les groupes pharmaceutiques bâlois et français vont construire une usine commune à Viège pour produire des médicaments biologiques Le fabricant…

Prexton Therapeutics lève 29 millions d’euros

Prexton Therapeutics lève 29 millions d’euros dans un second tour pour financer son traitement innovant dans la maladie de Parkinson…

Life Science to Turkey

Switzerland Global Enterprise is organizing a fact finding mission to Turkey for Swiss companies who would like to know more…

CAS Droit pharmaceutique et des biotechnologies

Derniers jours pour s’inscrire Le prochain volet de la formation continue en droit de la santé de l’Université de Neuchâtel…

Etude Lutathera à l’honneur dans le New England Journal of Medicine sur les patients atteints de TNE

AAA, société pharmaceutique installée dans l’arc lémanique et possédant des bureaux à Genève, annonce la publication de ses résultats de…

Medistri 2017 Expansion project

Started in 2006, Medistri is starting the building extension. The company, expert in Sterilisation and Lab testing for med devices,…